Form990
Click to see attachment
Department of the Treasury
Internal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except black lung benefit trust or private foundation)

MediumBullet The organization may have to use a copy of this return to satisfy state reporting requirements.
OMB No. 1545-0047
2010
Open to Public Inspection
A For the calendar year, or tax year beginning 07-01-2010 and ending 06-30-2011
BCheck if applicable:
CName of organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Doing Business As
 
 
Number and street (or P.O. box if mail is not delivered to street address)
1311 MAMARONECK AVE
ROOM/SUITE 310
Room/suite
City or town, state or country, and ZIP + 4
WHITE PLAINS, NY10605
D Employer identification number

13-5644916
E Telephone number

G Gross receipts $ 372,308,194
F Name and address of principal officer:
JOHN WALTER
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
WWW.LLS.ORG
H(a)
Is this a group return for
affiliates?
H(b)
Are all affiliates included?
If "No," attach a list. (see instructions)
H(c)
Group exemption number MediumBullet  
K Form of organization:
 
L Year of formation: 1949
M State of legal domicile: NY
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: THE LEUKEMIA & LYMPHOMA SOCIETY'S MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) .... 3 24
4 Number of independent voting members of the governing body (Part VI, line 1b) .... 4 23
5 Total number of individuals employed in calendar year 2010 (Part V, line 2a) ... 5 1,923
6 Total number of volunteers (estimate if necessary) .... 6 3,000,000
7a Total unrelated business revenue from Part VIII, column (C), line 12 .. 7a -1,562
b Net unrelated business taxable income from Form 990-T, line 34 .. 7b  
Revenues; Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 238,276,411 270,364,921
9 Program service revenue (Part VIII, line 2g) .........   0
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 5,945,189 10,990,644
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e) 2,522,446 2,476,936
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)................... 246,744,046 283,832,501
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 85,577,867 109,608,495
14 Benefits paid to or for members (Part IX, column (A), line 4) ....   0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10) 81,834,903 83,658,857
16a Professional fundraising fees (Part IX, column (A), line 11e).... 9,299,646 9,810,826
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet45,446,413    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24f).... 73,769,925 77,762,946
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 250,482,341 280,841,124
19 Revenue less expenses. Subtract line 18 from line 12...... -3,738,295 2,991,377
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............ 221,660,340 224,271,874
21 Total liabilities (Part X, line 26)............ 112,213,271 104,487,981
22 Net assets or fund balances. Subtract line 21 from line 20 ..... 109,447,069 119,783,893
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title.
Paid Preparer's Use Only Preparer's
signatureBig Right Arrow 		Date
right pointing bullet image Preparer’s taxpayer identification number
(see instructions)
Firm’s name (or yours
if self-employed),
address, and ZIP + 4Big Right Arrow




 		EIN right pointing bullet image
Phone no. right pointing bullet image
May the IRS discuss this return with the preparer shown above? (see instructions) .........
For Privacy Act and Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y
Form 990 (2010)
Form 990 (2010)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response to any question in this Part III . . . . . . . . . .
1
Briefly describe the organization’s mission: THE LEUKEMIA & LYMPHOMA SOCIETY'S MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES.
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? ....................
If “Yes,” describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program services? ..........................
If “Yes,” describe these changes on Schedule O.
4
Describe the exempt purpose achievements for each of the organization’s three largest program services by expenses.
Section 501(c)(3) and 501(c)(4) organizations and section 4947(a)(1) trusts are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 68,985,389 including grants of $ 66,082,184 ) (Revenue $   )
A) RESEARCH PROGRAMS: WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, LLS FUNDS EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVED OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS, AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. LLS IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS AS SOON AS POSSIBLE. (CONTINUED ON SCHEDULE O) TO DATE, LLS HAS INVESTED MORE THAN 814 MILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2011, LLS SUPPORTED RESEARCH IN THE U.S., CANADA, AND 10 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF MORE THAN 66 MILLION. OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: -BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN BLOOD CANCER RESEARCH FIELDS. -TURNING DISCOVERIES INTO CLINICAL PROGRESS: BASIC SCIENCE DISCOVERIES MUST BE TRANSLATED INTO NEW, SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. -SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. -FILLING A VOID: PROMISING RESEARCH PROJECTS THAT ARE HIGH-RISK AND/OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY THE GOVERNMENT OR BY FOR-PROFIT COMPANIES, BUT MAY PROVIDE IMPORTANT ADVANCES. -INCREASING ACCESS TO CLINICAL TRIALS: PARTNERING WITH LEADING CLINICAL TRIAL CENTERS CAN ACCELERATE THE CLINICAL TESTING OF NEW BLOOD CANCER THERAPIES THAT ARE OFTEN A PATIENT'S BEST CHANCE FOR CURE. LLS RESEARCH PROGRAMS ARE BASED ON THE BELIEF THAT SCIENTIFICALLY SOUND APPROACHES TOWARD CURES FOR, OR CONTROL OF, BLOOD CANCERS SHOULD BE SUPPORTED WORLDWIDE.TWO MAJOR INTEGRATED RESEARCH FUNDING PROGRAMS THE RESEARCH GRANT PROGRAM AND THE THERAPY ACCELERATION PROGRAM HAVE ADVISORY INPUT FROM WORLD RENOWNED BIOMEDICAL RESEARCH EXPERTS. TOGETHER THESE PROGRAMS: -SUPPORT THE ENTIRE RESEARCH CONTINUUM NEEDED TO IMPROVE OUTCOMES FOR BLOOD CANCER PATIENTS FROM BASIC LABORATORY SCIENCE TO CLINICAL TRIALS OF NEW AGENTS AND FROM INVESTIGATOR INITIATED RESEARCH TO MULTIDISCIPLINARY ACADEMIC COLLABORATIONS AND PRIVATE SECTOR DRUG DEVELOPMENT ALLIANCES. -ARE AIMED AT THE EFFECTIVE DISCOVERY AND DEVELOPMENT OF NEW AND BETTER THERAPIES FOR PEOPLE WITH BLOOD CANCER, AND, THROUGH A RESEARCH INITIATIVE LAUNCHED IN 2009, SUPPORT THE DEVELOPMENT OF MEASURES TO PREVENT OR SIGNIFICANTLY REDUCE POTENTIAL LONG-TERM AND LATE TOXICITIES OF TODAY'S CURATIVE THERAPIES. RESEARCH GRANT PROGRAM THE RESEARCH GRANT PROGRAM PROVIDES GRANT FUNDING TO SUPPORT SCIENTIFIC STUDIES AT ACADEMIC CENTERS IN THE UNITED STATES AND THROUGHOUT THE WORLD, THROUGH THREE GRANT MECHANISMS: 1. THE CAREER DEVELOPMENT PROGRAM (CDP) PROVIDES STIPENDS TO INVESTIGATORS OF EXCEPTIONAL PROMISE IN THE EARLY STAGES OF THEIR CAREERS, HELPING THEM TO DEVOTE THEIR CAREERS TO LEUKEMIA, LYMPHOMA AND/OR MYELOMA RESEARCH. THIS PROGRAM IS STRATIFIED INTO TWO SEPARATELY REVIEWED PROGRAMS IN BASIC OR CLINICAL RESEARCH: -BASIC RESEARCH "SCHOLARS ARE AWARDED UP TO 110,000 A YEAR FOR A TOTAL OF UP TO 550,000 OVER FIVE YEARS. "SPECIAL FELLOWS ARE AWARDED UP TO 65,000 A YEAR FOR A TOTAL OF UP TO 195,000 OVER THREE YEARS. "FELLOWS ARE AWARDED UP TO 55,000 A YEAR FOR A TOTAL OF UP TO 165,000 OVER THREE YEARS. -CLINICAL RESEARCH "SCHOLARS IN CLINICAL RESEARCH ARE AWARDED UP TO 110,000 A YEAR FOR A TOTAL OF UP TO 550,000 OVER FIVE YEARS. "SPECIAL FELLOWS IN CLINICAL RESEARCH ARE AWARDED UP TO 65,000 A YEAR FOR A TOTAL OF UP TO 195,000 OVER THREE YEARS. 2. THE TRANSLATIONAL RESEARCH PROGRAM (TRP) SUPPORTS OUTSTANDING INVESTIGATIONS DEEMED BY OUR EXPERT ADVISORS MOST LIKELY TO TRANSLATE BASIC BIOMEDICAL DISCOVERIES INTO NEW, SAFE AND EFFECTIVE TREATMENTS, ULTIMATELY PROLONGING AND ENHANCING PATIENTS' LIVES. TRANSLATIONAL RESEARCH AWARDS ARE MADE FOR AN INITIAL THREE-YEAR PERIOD. AWARDS UP TO 200,000 PER YEAR FOR THREE YEARS, FOR A TOTAL OF UP TO 600,000, ARE GRANTED EACH YEAR. FUNDING FOR TWO ADDITIONAL YEARS MAY BE PROVIDED FOR HIGHLY PROMISING PROJECTS THAT ARE ENTERING PHASE 1 CLINICAL TRIALS. THUS, RESEARCH REACHING A CLINICAL TRIAL CAN RECEIVE UP TO 1 MILLION OVER FIVE YEARS TO FACILITATE NEW DRUG DISCOVERY OR ADVANCES IN DIAGNOSIS OR PREVENTION. IN 2011, LLS ACTIVELY REQUESTED PROPOSALS TO HELP STIMULATE MORE ACADEMIC RESEARCH IN THREE UNDERDEVELOPED YET IMPORTANT AREAS OF RESEARCH. THE RESEARCH TOPICS EMPHASIZED WERE: 1) THE MALIGNANT STEM CELL IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES; 2) NON-CUTANEOUS T-CELL LEUKEMIAS AND LYMPHOMAS AND 3) HIGH RISK MYELOMA CASES. IN ADDITION, A REQUEST FOR RESEARCH FOCUSED ON LONG-TERM AND LATE EFFECTS OF BLOOD CANCER THERAPIES WAS EXTENDED INTO A SECOND YEAR. PROGRESS IN THESE RESEARCH AREAS IS DEEMED LIKELY TO IMPROVE OUTCOMES FOR PATIENTS WITH PARTICULARLY URGENT NEEDS. 3. THE MARSHALL A. LICHTMAN SPECIALIZED CENTER OF RESEARCH PROGRAM (SCOR) ENCOURAGES MULTIDISCIPLINARY RESEARCH BY LEADING-EDGE ACADEMIC INVESTIGATORS IN TEAMS OF AT LEAST THREE RESEARCH GROUPS THAT INTERACT TO FOSTER ADVANCES IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF BLOOD CANCERS. EACH SCOR GROUP IS FUNDED UP TO 1.25 MILLION PER YEAR OVER A FIVE-YEAR PERIOD, WITH A TOTAL AMOUNT OF UP TO 6.25 MILLION. AWARDS GO TO THOSE GROUPS THAT BEST DEMONSTRATE SYNERGISTIC EXPERTISE IN COMPLEMENTARY AREAS . THE PARTICIPATING SCIENTISTS MAY BE AT DIFFERENT INSTITUTIONS OR FROM ANY COUNTRY. THE GRANT REVIEW PROCESS FOR THE RESEARCH GRANT PROGRAM. SCIENTISTS AND PHYSICIAN SCIENTISTS WHO ARE EXPERTS IN THE FIELD OF BLOOD CANCER RESEARCH VOLUNTEER THEIR SERVICE TO CONSTITUTE PEER-REVIEW SUBCOMMITTEES FOR BASIC RESEARCH CDP, CLINICAL RESEARCH CDP, TRP AND SCOR. THESE COMMITTEES EVALUATE ALL GRANT APPLICATIONS IN THOSE PROGRAMS AND SELECT THOSE APPLICANTS WITH THE MOST INNOVATIVE AND IMPORTANT PROJECTS TO ADVANCE THE MISSION OF LLS. GUIDELINES, INSTRUCTIONS AND APPLICATIONS FOR THE THREE LLS RESEARCH PROGRAMS MAY BE OBTAINED BY VISITING WWW.LLS.ORG OR BY EMAILING RESEARCHPROGRAMS@LLS.ORG. THERAPY ACCELERATION PROGRAM THE THERAPY ACCELERATION PROGRAM (TAP) IS A STRATEGIC LLS INITIATIVE LAUNCHED IN 2007 WITH 4 MILLION IN SEED FUNDING. THE PROGRAM ACCELERATES NEW AND POTENTIALLY BETTER TREATMENTS AND CLINICAL TESTS INTO PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS. WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS AND COMPANIES, TAP IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE MADE AVAILABLE TO PATIENTS AS SOON AS POSSIBLE. TAP ENCOMPASSES THREE INNOVATIVE EFFORTS: 1. THE ACADEMIC CONCIERGE DIVISION IDENTIFIES CURRENT LLS FUNDED RESEARCH WITH THE GREATEST CLINICAL PROMISE AND PROVIDES THE FUNDING AND SUPPORT NEEDED TO ADVANCE SELECTED PROJECTS TO THE PRODUCT STAGE. 2.THE CLINICAL TRIALS DIVISION PARTNERS LLS WITH ONE OF THE COUNTRY'S LEADING CLINICAL TRIAL CENTERS TO ACCELERATE THE TESTING OF NEW BLOOD CANCER THERAPIES IN CLINICAL TRIALS. 3. THE BIOTECHNOLOGY ACCELERATOR DIVISION ALLIES LLS WITH COMPANIES TO COMBINE SCIENTIFIC AND FINANCIAL RESOURCES AND ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES THAT OTHERWISE WOULD NOT BE PRIORITIZED BY THE COMPANY. THE TAP PROJECT REVIEW PROCESS INVOLVES DUE DILIGENCE BY AN LLS STAFF TEAM OF DRUG DEVELOPMENT SPECIALISTS IN CONCERT WITH A VOLUNTEER PANEL OF LEADING BIOTECHNOLOGY AND PHARMACEUTICAL COMPANY EXECUTIVES AND INTELLECTUAL PROPERTY AND BUSINESS DEVELOPMENT EXPERTS. THE LEARNING COLLABORATIVE IN 2011, LLS BEGAN A UNIQUE COLLABORATION WITH THE UNIVERSITY OF KANSAS CANCER CENTER AND THE NATIONAL INSTITUTES OF HEALTH TO ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES FOR RARE BLOOD CANCERS. THIS COLLABORATION, KNOWN AS THE LEARNING COLLABORATIVE, BRINGS TOGETHER PROVEN EXPERTISE IN BLOOD CANCER RESEARCH AS WELL AS DRUG DISCOVERY AND DEVELOPMENT TO RAPIDLY ADVANCE PROMISING NEW THERAPIES FROM THE BENCH TO THE BEDSIDE. IF SUCCESSFUL, THE LEARNING COLLABORATIVE'S NOVEL MODEL WILL DEMONSTRATE THAT GOVERNMENT, ACADEMIA, DISEASE PHILANTHROPY AND INDUSTRY CAN SUCCESSFULLY PARTNER TO SAFELY AND EFFICIENTLY ADVANCE NEW OR REPURPOSED DRUG THERAPIES TO PATIENTS.
4b (Code:   ) (Expenses $ 99,695,257 including grants of $ 43,526,311 ) (Revenue $   )
B) PATIENT & COMMUNITY SERVICES : AN ESTIMATED 1,012,533 PEOPLE ACROSS THE UNITED STATES (US) CURRENTLY BATTLE LEUKEMIA, LYMPHOMA AND MYELOMA. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) OFFERS THE MOST COMPREHENSIVE ARRAY OF SERVICES TO BLOOD CANCER PATIENTS AND THEIR FAMILIES. LAST YEAR ALONE, LLS MADE 7.1 MILLION CONTACTS WITH PATIENTS, CAREGIVERS, HEALTHCARE PROFESSIONALS AND THE PUBLIC. (CONTINUED ON SCHEDULE O) CHAPTER-BASED PROGRAMS: EACH LLS CHAPTER IS STAFFED WITH A PATIENT SERVICES MANAGER WHO OVERSEES THE CHAPTER'S SERVICES TO PATIENTS AND THEIR FAMILIES. PATIENT SERVICES MANAGERS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. COMMUNITY BASED EDUCATION, INCLUDING THE FOLLOWING FOUR PROGRAMS, ARE OFFERED THROUGH ALL THE CHAPTERS - 38,959 PATIENT AND CAREGIVER PARTICIPANTS IN 2011 - 12,236 HEALTHCARE PROFESSIONAL PARTICIPANTS IN 2011 IMPROVING TREATMENTS FOR BLOOD CANCERS: WHAT YOU NEED TO KNOW TO MAKE INFORMED DECISIONS THIS PROGRAM DETAILS NEW TREATMENT DEVELOPMENT, TREATMENT DECISIONS (STANDARD OF CARE VERSUS CLINICAL TRIALS) AND HOW PATIENTS CAN COMMUNICATE MORE EFFECTIVELY WITH THEIR MEDICAL TEAMS. MYELOMA UPDATE: DIAGNOSIS, TREATMENT AND SIDE EFFECTS MANAGEMENT THIS PROGRAM PROVIDES PATIENTS, FAMILY MEMBERS AND CAREGIVERS WITH THE LATEST INFORMATION ON MYELOMA AND MYELOMA THERAPY, INCLUDING A QUESTION AND ANSWER SESSION WITH A MEDICAL EXPERT IN THEIR COMMUNITY. GETTING THE BEST CANCER CARE AT AGE 55 AND OLDER THIS EDUCATION PROGRAM PRESENTS AN OVERVIEW OF THE MANY FACTORS, NOT AGE ALONE, THAT HEALTHCARE PROFESSIONALS SHOULD ASSESS TO DETERMINE AN APPROPRIATE CANCER TREATMENT PLAN FOR AN OLDER ADULT. WELCOME BACK: WORKING TOGETHER TO SUPPORT THE CANCER SURVIVOR AT SCHOOL THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN IMPROVE THE TRANSITION OF CANCER SURVIVORS FROM CLINIC TO CLASSROOM. SUPPORT SERVICES: FAMILY SUPPORT GROUPS LLS HAS DEVELOPED 452 FAMILY SUPPORT GROUPS AT CHAPTERS THROUGHOUT THE US AND CANADA. LLS ALSO HAS 825 VOLUNTEER SUPPORT GROUP FACILITATORS WITH BACKGROUNDS IN ONCOLOGY NURSING OR SOCIAL WORK. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, AND PROVIDE INFORMATION AND SUPPORT AND ENCOURAGE GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTH CARE PROFESSIONALS. - 13,108 PARTICIPANTS IN FAMILY SUPPORT GROUPS IN 2011 PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. - 5,094 FIRST CONNECTIONS IN 2011 PATIENT FINANCIAL AID PROGRAM FOR MORE THAN 45 YEARS, LLS HAS HELPED PATIENTS DEMONSTRATING SIGNIFICANT NEED TO OBTAIN FINANCIAL ASSISTANCE TO COVER A PORTION OF THEIR TREATMENT COSTS. THE LLS PATIENT FINANCIAL AID PROGRAM PROVIDES A LIMITED AMOUNT OF FINANCIAL ASSISTANCE TO HELP PATIENTS WITH SIGNIFICANT FINANCIAL NEED AND WHO ARE UNDER A DOCTOR'S CARE FOR A CONFIRMED BLOOD CANCER DIAGNOSIS. PATIENT FINANCIAL AID FUNDS ARE SUBJECT TO AVAILABILITY. - 37,210 PATIENTS RECEIVED FINANCIAL AID IN 2011 CO-PAY ASSISTANCE PROGRAM THIS ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. - 13,130 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2011 THE TRISH GREENE BACK TO SCHOOL PROGRAM FOR CHILDREN WITH CANCER THIS PROGRAM IS DESIGNED TO INCREASE COMMUNICATION AMONG HEALTH CARE PROFESSIONALS, PARENTS, PATIENTS AND SCHOOL PERSONNEL TO ASSURE YOUNGSTERS A SMOOTH TRANSITION FROM ACTIVE TREATMENT BACK TO SCHOOL. PRINTED LITERATURE, VIDEOS AND OTHER MATERIALS TO AID THE PROCESS ARE AVAILABLE THROUGH ALL LOCAL CHAPTERS, INCLUDING: "WELCOME BACK: WORKING TOGETHER TO SUPPORT THE CANCER SURVIVOR AT SCHOOL". THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN IMPROVE THE TRANSITION OF CANCER SURVIVORS FROM CLINIC TO CLASSROOM. - 3,219 SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS PARTICIPATED IN THE 74 WELCOME BACK PROGRAMS ACROSS THE US AND CANADA "LEARNING AND LIVING WITH CANCER: ADVOCATING FOR YOUR CHILD'S EDUCATIONAL NEEDS" THIS BOOKLET OFFERS PARENTS INFORMATION ON THE LEARNING CHALLENGES CHILDREN MAY FACE DURING AND AFTER CANCER TREATMENT, LAWS THAT PROTECT THE EDUCATIONAL NEEDS OF CHILDREN WITH CANCER AND SPECIFIC WAYS THAT SCHOOLS CAN HELP MEET A CHILD'S EDUCATIONAL NEEDS
4c (Code:   ) (Expenses $ 38,403,332 including grants of $   ) (Revenue $   )
C) PUBLIC HEALTH EDUCATION: INFORMATION AND EDUCATION NATIONAL PROGRAMS: INFORMATION RESOURCE CENTER LLS INFORMATION SPECIALISTS ARE MASTER'S LEVEL ONCOLOGY SOCIAL WORKERS, NURSES AND HEALTH EDUCATORS WHO PROVIDE HELP WITH DISEASE, TREATMENT AND CLINICAL TRIALS INFORMATION AND SUPPORT. (CONTINUED ON SCHEDULE O) PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS MAY SPEAK TO AN INFORMATION SPECIALIST AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 6 P.M., ET OR EMAIL INFOCENTER@LLS.ORG. - 69,777 INQUIRIES IN 2011 - TRANSLATION SERVICES AVAILABLE IN MORE THAN 165 LANGUAGES ONLINE ENGAGEMENT THE LLS WEBSITE SERVES A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. USERS CAN PERSONALIZE THEIR LLS WEB PAGES TO KEEP CURRENT WITH DISEASE SPECIFIC UPDATES AND LOCAL CHAPTER EDUCATION, SUPPORT AND EVENT ACTIVITIES. THE SITE FEATURES A COMPREHENSIVE OVERVIEW OF LLS PROGRAMS AND SERVICES, FAMILY SUPPORT GROUP LOCATIONS, INFORMATION ABOUT OUR PEER-TO-PEER PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM, AND OTHER PROGRAMS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS IN CONVENIENT AND PERSONAL WAYS THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. - 5.8 MILLION UNIQUE VISITS TO WWW.LLS.ORG IN 2011, WITH MORE THAN 7.5 MILLION PAGE VIEWS - 409,799 UNIQUE VISITS TO OUR BLOOD CANCER DISCUSSION BOARDS - 157,877 TELECONFERENCE DOWNLOADS - 208,822 SUBSCRIBERS TO OUR DISEASE SPECIFIC ENEWSLETTERS, WHICH ARE ISSUED ON A MONTHLY BASIS - 116,797 FOLLOWERS OF OUR PATIENT AND CAREGIVER COMMUNITY ONLINE TELEPHONE & WEB EDUCATION PROGRAMS LLS SPONSORS TELEPHONE AND WEB EDUCATION PROGRAMS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTHCARE PROFESSIONALS ABOUT LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. UPCOMING PROGRAMS ARE POSTED AT WWW.LLS.ORG/PROGRAMS AND ARCHIVES OF PAST PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PASTPROGRAMS. - 251,077 TELEPHONE AND WEB-BASED PROGRAM PARTICIPANTS IN 2011 EDUCATION MATERIALS AN EXTENSIVE CATALOG OF EDUCATION MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTHCARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LOCAL LLS CHAPTERS. - 1,061,018 PRINTED BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS DISTRIBUTED IN 2011 MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/RESOURCECENTER. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH, SPANISH AND FRENCH.
(Code:   ) (Expenses $ 7,774,360 including grants of $   ) (Revenue $   )
D) PROFESSIONAL EDUCATION: LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT.
4d Other program services. (Describe in Schedule O.)
(Expenses $ 7,774,360 including grants of $   ) (Revenue $   )
4e Total program service expensesMediumBullet$ 214,858,338
Form 990 (2010)
Form 990 (2010)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If “Yes,” complete Schedule AClick to see attachment.....................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors? Click to see attachment........
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If “Yes,” complete Schedule C, Part IClick to see attachment..........
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities? If “Yes,” complete Schedule C,
Part IIClick to see attachment.........................
4
Yes
 
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If “Yes,” complete Schedule C, Part IIIClick to see attachment........................
5
 
No
6
Did the organization maintain any donor advised funds or any similar funds or accounts where donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If “Yes,” complete
Schedule D, Part IClick to see attachment.......................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas or historic structures? If “Yes,” complete Schedule D, Part IIClick to see attachment...
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If “Yes,” complete Schedule D, Part III Click to see attachment....................
8
Yes
 
9
Did the organization report an amount in Part X, line 21; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If “Yes,”
complete Schedule D, Part IVClick to see attachment...................
9
 
No
10
Did the organization, directly or through a related organization, hold assets in term, permanent,or quasi-endowments? If “Yes,” complete Schedule D, Part VClick to see attachment
10
Yes
 
11
If the organization’s answer to any of the following questions is ‘Yes,’ then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable:
a
Did the organization report an amount for land, buildings, and equipment in Part X, line10? If “Yes,” complete Schedule D, Part VI.Click to see attachment
11a
Yes
 
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part VII.Click to see attachment
11b
Yes
 
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part VIII.Click to see attachment
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If “Yes,” complete Schedule D, Part IX.Click to see attachment
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If “Yes,” complete Schedule D, Part X.Click to see attachment
11e
 
No
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If “Yes,” complete Schedule D, Part X.Click to see attachment
11f
Yes
 
12a
Did the organization obtain separate, independent audited financial statements for the tax year? If “Yes,” complete Schedule D, Parts XI, XII, and XIII Click to see attachment
12a
 
No
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If “Yes,” and if the organization answered ‘No’ to line 12a, then completing Schedule D, Parts XI, XII, and XIII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If “Yes,” complete Schedule E
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States?....
14a
Yes
 
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, and program service activities outside the United States? If “Yes,” complete Schedule F, Part I......... Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or assistance to any organization or entity located outside the U.S.? If “Yes,” complete Schedule F, Part II.. Click to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or assistance to individuals located outside the U.S.? If “Yes,” complete Schedule F, Part III.. Click to see attachment
16
 
No
17
Did the organization report a total of more than $15,000, of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If “Yes,” complete Schedule G, Part IClick to see attachment
17
Yes
 
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If “Yes,” complete Schedule G, Part II.......... Click to see attachment
18
Yes
 
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If “Yes,” complete Schedule G, Part III................... Click to see attachment
19
Yes
 
Form 990 (2010)
Form 990 (2010)
Page 4
Part IV
Checklist of Required Schedules (continued)
20a
Did the organization operate one or more hospitals? If “Yes,” complete Schedule H.....
20a
 
No
b
Did the organization attach its audited financial statement to this return? Note: All Form 990 filers that operate one or more hospitals must attach audited financial statements. .....
20b
 
 
21
Did the organization report more than $5,000 of grants and other assistance to governments and organizations in the United States on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II.. Click to see attachment
21
Yes
 
22
Did the organization report more than $5,000 of grants and other assistance to individuals in the United States on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III..... Click to see attachment
22
Yes
 
23
Did the organization answer “Yes” to Part VII, Section A, questions 3, 4, or 5, about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If “Yes,” complete Schedule J................ Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer questions 24b–24d and complete Schedule K. If “No,” go to line 25................
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
 
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds?......................
24c
 
 
d
Did the organization act as an “on behalf of” issuer for bonds outstanding at any time during the year?...
24d
 
 
25a
Section 501(c)(3) and 501(c)(4) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If “Yes,” complete Schedule L, Part I...... Click to see attachment
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If “Yes,” complete Schedule L, Part I................ Click to see attachment
25b
 
No
26
Was a loan to or by a current or former officer, director, trustee, key employee, highly compensated employee, or disqualified person outstanding as of the end of the organization’s tax year? If “Yes,” complete Schedule L,
Part II........................... Click to see attachment
26
 
No
27
Did the organization provide a grant or other assistance to an officer, director, trustee, key employee, substantial contributor, or a grant selection committee member, or to a person related to such an individual? If “Yes,” complete Schedule L, Part III............... Click to see attachment
27
 
No
28
Was the organization a party to a business transaction with one of the following parties? (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, or key employee? If “Yes,” complete Schedule L, Part IV ......................... Click to see attachment
28a
Yes
 
b
A family member of a current or former officer, director, trustee, or key employee? If “Yes,”
complete Schedule L, Part IV................... Click to see attachment
28b
 
No
c
An entity of which a current or former officer, director, trustee, or key employee (or a family member thereof) was an officer, director, trustee, or owner? If “Yes,” complete Schedule L, Part IV.. Click to see attachment
28c
Yes
 
29
Did the organization receive more than $25,000 in non-cash contributions? If “Yes,” complete Schedule MClick to see attachment
29
Yes
 
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If “Yes,” complete Schedule M............ Click to see attachment
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If “Yes,” complete Schedule N,
Part I........................... Click to see attachment
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If “Yes,” complete Schedule N, Part II.......................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If “Yes,” complete Schedule R, Part I........ Click to see attachment
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If “Yes,” complete Schedule R, Parts II, III, IV, and V, line 1..................... Click to see attachment
34
Yes
 
35
Is any related organization a controlled entity within the meaning of section 512(b)(13)? .....
35
Yes
 
a
Did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If “Yes,” complete Schedule R, Part V, line 2... Click to see attachment
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If “Yes,” complete Schedule R, Part V, line 2........... Click to see attachment
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If “Yes,” complete Schedule R, Part VIClick to see attachment
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11 and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Form 990 (2010)
Form 990 (2010)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response to any question in this Part V . . . . . . . . . .
Yes
No
1a
Enter the number reported in Box 3 of Form 1096. Enter -0- if not applicable. .......
1a
1,262
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable.
1b
40
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
Yes
 
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and Tax Statements filed for the calendar year ending with or within the year covered by this return .....................
2a
1,923
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?

Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file. (see instructions)
2b
Yes
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?.............................
3a
Yes
 
b
If “Yes,” has it filed a Form 990-T for this year? If “No,” provide an explanation in Schedule O.....
3b
Yes
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account or securities account)?.......................
4a
Yes
 
b
If "Yes," enter the name of the foreign country: MediumBulletCA
See instructions for filing requirements for Form TD F 90-22.1, Report of Foreign Bank and Financial Accounts.
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year?..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If “Yes” to line 5a or 5b, did the organization file Form 8886-T? ........
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible?..........
6a
Yes
 
b
If “Yes,” did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible?........................
6b
Yes
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor?....................
7a
Yes
 
b
If “Yes,” did the organization notify the donor of the value of the goods or services provided?.....
7b
Yes
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282?...........................
7c
 
No
d
If “Yes,” indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?..........................
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract?..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required?...................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C?...............
7h
 
 
8
Sponsoring organizations maintaining donor advised funds and section 509(a)(3) supporting organizations. Did the supporting organization, or a donor advised fund maintained by a sponsoring organization, have excess business holdings at any time during the year?................
8
 
 
9
Sponsoring organizations maintaining donor advised funds.
a
Did the organization make any taxable distributions under section 4966?.........
9a
 
 
b
Did the organization make a distribution to a donor, donor advisor, or related person?......
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If “Yes,” enter the amount of tax-exempt interest received or accrued during the year.
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state?
Note. All 501(c)(29) organizations must list in Schedule O each state in which they are licensed to issue qualified health plans, the amount of reserves required by each state, and the amount of reserves the organization allocated to each state.
13a
 
 
b
Enter the aggregate amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans.
13b
 
c
Enter the aggregate amount of reserves on hand.
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
 
b
If "Yes," has it filed a Form 720 to report these payments? If “No,” provide an explanation in Schedule O..
14b
 
 
Form 990 (2010)
Form 990 (2010)
Page 6
Part VI
Governance, Management, and Disclosure For each “Yes” response to lines 2 through 7b below, and for a “No” response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response to any question in this Part VI . . . . . . . . . .
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year ..............
1a
24
b
Enter the number of voting members included in line 1a, above, who are independent .................
1b
23
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? ..
3
 
No
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed?
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Does the organization have members or stockholders? ................
6
Yes
 
7a
Does the organization have members, stockholders, or other persons who may elect one or more members of the governing body? .........................
7a
Yes
 
b
Are any decisions of the governing body subject to approval by members, stockholders, or other persons? ..
7b
Yes
 
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .........................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If “Yes,” provide the names and addresses in Schedule O .....
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal
Revenue Code.)
Yes
No
10a
Does the organization have local chapters, branches, or affiliates? ............
10a
Yes
 
b
If “Yes,” does the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with those of the organization? ....
10b
Yes
 
11a
Has the organization provided a copy of this Form 990 to all members of its governing body before filing the form?
11a
Yes
 
b
Describe in Schedule O the process, if any, used by the organization to review the Form 990. .....
12a
Does the organization have a written conflict of interest policy? If “No,” go to line 13.......
12a
Yes
 
b
Are officers, directors or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ...........................
12b
Yes
 
c
Does the organization regularly and consistently monitor and enforce compliance with the policy? If “Yes,” describe in Schedule O how this is done ....................
12c
Yes
 
13
Does the organization have a written whistleblower policy? ...............
13
Yes
 
14
Does the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
Yes
 
b
Other officers or key employees of the organization ................
15b
Yes
 
If "Yes" to line a or b, describe the process in Schedule O. (See instructions.)
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If “Yes,” has the organization adopted a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and taken steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the States with which a copy of this Form 990 is required to be filedMediumBullet
AK , AR , AZ , CA , CT , DE , FL , GA , IL , IN , KS , KY , LA , MA , MD , ME , MI , MN , MO , MS , NH , NJ , NM , NV , NY , OH , OK , OR , PA , PR , RI , SC , TN , UT , VA , WA , WI , WV
18
Section 6104 requires an organization to make its Form 1023 (or 1024 if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you make these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how), the organization makes its governing documents, conflict of interest policy, and financial statements available to the public.
20
State the name, physical address, and telephone number of the person who possesses the books and records of the organization: MediumBullet
JAMES T NANGLE
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605
(914) 949-5213
Form 990 (2010)
Form 990 (2010)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response to any question in this Part VII . . . . . . . . . .
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation, and current key employees. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

List persons in the following order: individual trustees or directors; institutional trustees; officers; key employees; highest
compensated employees; and former such persons.
Check this box if neither the organization nor any related organizations compensated any current or former officer, director, or trustee.
(A)
Name and Title 		(B)
Average hours per week (describe hours for related organizations in Schedule O) 		(C)
Position (check all that apply) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; Officer; Key Employee; Highest compensated employee; Former;
(1) JAMES A BECK
 
BOD MEMBER
 2.00 X           0 0 0
(2) JORGE L BENITEZ
BOD MEMBER
 2.00 X           0 0 0
(3) ELIZABETH J CLARK
BOD MEMBER
 2.00 X           0 0 0
(4) JORGE CORTES MD
BOD MEMBER
 2.00 X           0 0 0
(5) JAMES H DAVISPHD
BOD MEMBER
 2.00 X           0 0 0
(6) THOMAS L FITZPATRICK
BOD MEMBER
 2.00 X           0 0 0
(7) ALAN M GEWIRTZMD
BOD MEMBER
 2.00 X           0 0 0
(8) D GARY GILLILANDMD PHD
BOD MEMBER
 2.00 X           0 0 0
(9) STEVEN HOOKER
BOD MEMBER
 2.00 X           0 0 0
(10) RAANAN HOROWITZ
BOD MEMBER
 2.00 X           0 0 0
(11) JOHN M KAMINS
BOD MEMBER
 2.00 X           0 0 0
(12) ARMAND KEATINGMD
BOD MEMBER
 2.00 X           0 0 0
(13) JOSEPH B KELLEY
BOD MEMBER
 2.00 X           0 0 0
(14) MATTHEW WINTER
BOD MEMBER
 2.00 X           0 0 0
(15) RODMAN N MYERS
BOD MEMBER
 2.00 X           0 0 0
(16) DEREK RAGHAVANMDPHDFACP
BOD MEMBER
 2.00 X           0 0 0
(17) KENNETH M SCHWARTZ
BOD MEMBER
 2.00 X           0 0 0
Form 990 (2010)
Form 990 (2010)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and Title 		(B)
Average hours per week (describe hours for related organizations in Schedule O) 		(C)
Position (check all that apply) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; Officer; Key Employee; Highest compensated employee; Former;
(18) NORBERT J SIEBER
BOD MEMBER
 2.00 X           0 0 0
(19) JAY L SILVER
BOD MEMBER
 2.00 X           0 0 0
(20) WILLIAM M WARD JR
BOD MEMBER
 2.00 X           0 0 0
(21) LOUISE E WARNER
BOD MEMBER
 2.00 X           0 0 0
(22) MICHELE C WONG
BOD MEMBER
 2.00 X           0 0 0
(23) JOHN WALTER
PRESIDENT &
 45.00     X       519,525 0 52,493
(24) JAMES T NANGLE
SVP&CFO
 45.00     X       232,816 0 43,907
(25) SCOTT A CARROLL
CHAIR
 2.00     X       0 0 0
(26) TIMOTHY DURST
VICE CHAIR
 2.00     X       0 0 0
(27) KEVIN R RYAN
SECRETARY/TR
 2.00     X       0 0 0
(28) LOUIS DEGENNARO
EVP,CHIEF MI
 45.00         X   346,056 0 39,109
(29) NANCY KLEIN
CHIEF MARKET
 45.00         X   337,570 0 46,123
(30) DAVID TIMKO
SVP CHAPTER
 45.00         X   247,464 0 38,060
(31) MICHAEL OSSO
SVP,REVENUE
 45.00         X   230,521 0 29,514
(32) GEORGE OMIROS
SVP FIELD DE
 45.00         X   219,956 0 35,609
1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)............MediumBullet 2,133,908   284,815
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 in reportable compensation from the organizationMediumBullet86
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If “Yes,” complete Schedule J for such individual .............
3
 
No
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If “Yes,” complete Schedule J for such individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If “Yes,” complete Schedule J for such person .....
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
PARADYZ MATERA
5 HANOVER SQUARE
6TH FLOOR
NEW YORK,NY10004 		FUNDRAISING SER 3,852,425
DIRECT PRINT COMMUNICATIONS
201 EAST SANDPOINTE
SUITE 400
SANTA ANA,CA92707 		FUNDRAISING SER 2,515,663
INFOCISION MANAGEMENT CORPORATION
325 SPRINGSIDE DRIVE
AKRON,OH44333 		FUNDRAISING SER 2,210,192
MSP
PO BOX 641114
PITTSBURGH,PA15264 		FUNDRAISING SER 2,100,315
YORK LABEL
36877 TREASURY CENTER
CHICAGO,IL60694 		FUNDRAISING SER 1,653,978
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 in compensation from the organization MediumBullet55
Form 990 (2010)
Form 990 (2010)
Page 9
Part VIII
Statement of Revenue
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512, 513, or 514
Contributions, gifts, grants and other similar amounts 1a Federated campaigns..1a 2,465,953
b Membership dues....1b  
c Fundraising events....1c 154,840,995
d Related organizations...1d  
e Government grants (contributions)1e 520,836
f All other contributions, gifts, grants, and
similar amounts not included above1f 		112,537,137
g Noncash contributions included in lines 1a-1f:$ 962,451
h Total. Add lines 1a-1f.......MediumBullet 270,364,921
Program Service Revenue Business Code
2a
b
c
d
e
f All other program service revenue .        
g Total. Add lines 2a–2f........MediumBullet  
Other Revenue 3 Investment income (including dividends, interest
and other similar amounts).....MediumBullet 3,135,664     3,135,664
4 Income from investment of tax-exempt bond proceeds..MediumBullet        
5 Royalties............MediumBullet 9,973     9,973
(i) Real (ii) Personal
6a Gross Rents    
b Less: rental expenses    
c Rental income or (loss)    
d Net rental income or (loss).......MediumBullet        
(i) Securities (ii) Other
7a Gross amount from sales of assets other than inventory 59,867,900  
b Less: cost or other basis and sales expenses 52,012,920  
c Gain or (loss) 7,854,980  
d Net gain or (loss)..........MediumBullet 7,854,980   -1,562 7,856,542
8a Gross income from fundraising events (not including
$ 154,840,995
of contributions reported on line 1c). See Part IV, line 18 ...
a 36,412,083
b Less: direct expenses ...b 36,412,083
c Net income or (loss) from fundraising events..MediumBullet      
9a Gross income from gaming activities.
See Part IV, line 19 ...
a 738,168
b Less: direct expenses ...b 50,690
c Net income or (loss) from gaming activities...MediumBullet 687,478 687,478    
10a Gross sales of inventory, less
returns and allowances .
a  
b Less: cost of goods sold ..b  
c Net income or (loss) from sales of inventory..MediumBullet        
Miscellaneous Revenue Business Code
11a GRANT TERMINATION 541,900 1,748,113     1,748,113
b OTHER MISCELLANEOUS 900,099 31,372     31,372
c            
d All other revenue ....        
e Total. Add lines 11a–11d ......MediumBullet 1,779,485
12 Total revenue. See Instructions....MediumBullet 283,832,501 687,478 -1,562 12,781,664
Form 990 (2010)
Form 990 (2010)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A) but are not required to complete columns (B), (C), and (D).
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising expenses
1 Grants and other assistance to governments and organizations in the U.S. See Part IV, line 21 61,294,057 61,294,057
2 Grants and other assistance to individuals in the U.S. See Part IV, line 22 43,526,311 43,526,311
3 Grants and other assistance to governments, organizations, and individuals outside the U.S. See Part IV, lines 15 and 16 4,788,127 4,788,127
4 Benefits paid to or for members    
5 Compensation of current officers, directors, trustees, and key employees .... 895,935 675,482 99,303 121,150
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) ....        
7 Other salaries and wages 63,212,997 47,658,872 7,006,360 8,547,765
8 Pension plan contributions (include section 401(k) and section 403(b) employer contributions) .... 3,916,306 2,852,862 421,859 641,585
9 Other employee benefits ....... 10,999,355 8,012,560 1,184,836 1,801,959
10 Payroll taxes ........... 4,634,264 3,375,863 499,197 759,204
11 Fees for services (non-employees):        
a Management ......        
b Legal ......... 890,419 500,182 133,314 256,923
c Accounting ........... 284,308 159,706 42,567 82,035
d Lobbying ........... 164,800 92,572 24,674 47,554
e Professional fundraising. See Part IV, line 17.. 9,810,826 9,810,826
f Investment management fees ...... 701,540 394,081 105,036 202,423
g Other .......... 14,394,331 8,085,841 2,155,133 4,153,357
12 Advertising and promotion .... 4,106,918 1,762,928 759,276 1,584,714
13 Office expenses .......        
14 Information technology ...... 3,845,633 2,160,237 575,772 1,109,624
15 Royalties ..        
16 Occupancy ........... 8,212,389 5,984,218 944,956 1,283,215
17 Travel ............ 3,320,436 2,445,830 394,227 480,379
18 Payments of travel or entertainment expenses for any federal, state, or local public officials ......        
19 Conferences, conventions, and meetings .... 3,251,767 2,848,153 180,213 223,401
20 Interest ...........        
21 Payments to affiliates .......        
22 Depreciation, depletion, and amortization ..... 2,054,800 1,448,640 205,648 400,512
23 Insurance .............. 515,497 377,947 45,472 92,078
24 Other expenses. Itemize expenses not covered above. (Expenses grouped together and labeled miscellaneous may not exceed 5% of total expenses shown on line 25 below.)
a PRINTING 17,782,487 7,633,273 3,287,580 6,861,634
b POSTAGE 11,658,784 4,325,172 1,844,493 5,489,119
c TELEPHONE 3,560,220 2,304,559 268,953 986,708
d MISCELLANEOUS 2,747,539 2,034,503 307,388 405,648
e DUES & SUBSCRIPTIONS 271,078 116,362 50,116 104,600
f All other expenses        
25 Total functional expenses. Add lines 1 through 24f 280,841,124 214,858,338 20,536,373 45,446,413
26 Joint costs. Check here MediumBullet if following
SOP 98-2 (ASC 958-720). Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation 		21,788,322 10,485,257   11,303,065
Form 990 (2010)
Form 990 (2010)
Page 11
Part X Balance Sheet
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash—non-interest-bearing ..........   1  
2 Savings and temporary cash investments ....... 19,677,285 2 15,624,105
3 Pledges and grants receivable, net ......... 16,815,436 3 19,055,089
4 Accounts receivable, net ......... 199,138 4 328,134
5 Receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of
Schedule L ..........   5  
6 Receivables from other disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B). Complete Part II of
Schedule L ..........   6  
7 Notes and loans receivable, net .............   7  
8 Inventories for sale or use ..............   8  
9 Prepaid expenses and deferred charges ............ 4,262,608 9 4,423,864
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a 13,640,725
b Less: accumulated depreciation. ..... 10b 8,458,416 5,006,438 10c 5,182,309
11 Investments—publicly traded securities .......... 128,755,483 11 128,104,890
12 Investments—other securities. See Part IV, line 11 ...... 46,943,952 12 51,553,483
13 Investments—program-related. See Part IV, line 11 ..   13  
14 Intangible assets .........   14  
15 Other assets. See Part IV, line 11 ...........   15  
16 Total assets. Add lines 1 through 15 (must equal line 34)... 221,660,340 16 224,271,874
Liabilities 17 Accounts payable and accrued expenses . 15,911,173 17 17,155,530
18 Grants payable .......... 79,972,494 18 70,833,146
19 Deferred revenue .......... 16,329,604 19 16,499,305
20 Tax-exempt bond liabilities ..........   20  
21 Escrow or custodial account liability. Complete Part IV of Schedule D..   21  
22 Payables to current and former officers, directors, trustees, key
employees, highest compensated employees, and disqualified
persons. Complete Part II of Schedule L..........   22  
23 Secured mortgages and notes payable to unrelated third parties ..   23  
24 Unsecured notes and loans payable to unrelated third parties ....   24  
25 Other liabilities. Complete Part X of Schedule D.....   25  
26 Total liabilities. Add lines 17 through 25..... 112,213,271 26 104,487,981
Net Assets or Fund Balance Organizations that follow SFAS 117, check here MediumBullet and complete lines 27 through 29, and lines 33 and 34.
27 Unrestricted net assets ..... 87,166,990 27 93,670,008
28 Temporarily restricted net assets ..... 19,507,519 28 23,328,394
29 Permanently restricted net assets ..... 2,772,560 29 2,785,491
Organizations that do not follow SFAS 117, check here MediumBullet and complete lines 30 through 34.
30 Capital stock or trust principal, or current funds .....   30  
31 Paid-in or capital surplus, or land, building or equipment fund .....   31  
32 Retained earnings, endowment, accumulated income, or other funds   32  
33 Total net assets or fund balances ..... 109,447,069 33 119,783,893
34 Total liabilities and net assets/fund balances ..... 221,660,340 34 224,271,874
Form 990 (2010)
Form 990 (2010)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response to any question in this Part XI . . . . . . . . . .
1
Total revenue (must equal Part VIII, column (A), line 12) . . .
1
283,832,501
2
Total expenses (must equal Part IX, column (A), line 25) . . . . .
2
280,841,124
3
Revenue less expenses. Subtract line 2 from line 1 . . . .
3
2,991,377
4
Net assets or fund balances at beginning of year (must equal Part X, line 33, column (A)) . .
4
109,447,069
5
Other changes in net assets or fund balances (explain in Schedule O) . . . .
5
7,345,447
6
Net assets or fund balances at end of year. Combine lines 3, 4, and 5 (must equal Part X, line 33, column (B)) . . . . . .
6
119,783,893
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response to any question in this Part XII . . . . . . . . . .
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?..
2a
 
No
b
Were the organization’s financial statements audited by an independent accountant?........
2b
Yes
 
c
If “Yes,” to 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O............................
2c
Yes
 
d
If “Yes” to line 2a or 2b, check a box below to indicate whether the financial statements for the year were issued on a separate basis, consolidated basis, or both:
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133? ................
3a
 
No
b
If “Yes,” did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits. ..
3b
 
 
Form 990 (2010)
Additional Data


Software ID:  
Software Version:  
Form 990, Special Condition Description:
Special Condition Description
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support

Complete if the organization is a section 501(c)(3) organization or a section
4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ. right arrow See separate instructions.
OMB No. 1545-0047
2010
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions
The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)
1
2
3
4
5
section 170(b)(1)(A)(iv). (Complete Part II.)
6
7
8
9
receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of
its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses
acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)
10
11
e
f
g
(i) a person who directly or indirectly controls, either alone or together with persons described in (ii)
Yes
No
and (iii) below, the governing body of the the supported organization? ................
11g(i)
 
 
(ii) a family member of a person described in (i) above? ......................
11g(ii)
 
 
(iii) a 35% controlled entity of a person described in (i) or (ii) above? ................
11g(iii)
 
 
h
(i)
Name of supported organization 		(ii)
EIN 		(iii)
Type of organization (described on lines 1- 9 above or IRC section (see instructions)) 		(iv)
Is the organization in col. (i) listed in your governing document? 		(v)
Did you notify the organization in col. (i) of your support? 		(vi)
Is the organization in col. (i) organized in the U.S.? 		(vii)
Amount of support?
Yes No Yes No Yes No
Total                  

For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2010
Schedule A (Form 990 or 990-EZ) 2010
Page 2
Part II
Support Schedule for Organizations Described in IRC 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year(or fiscal year beginning in) (a) 2006 (b) 2007 (c) 2008 (d) 2009 (e) 2010 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... 246,772,831 256,914,242 269,310,797 238,864,532 271,052,399 1,282,914,801
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......            
3 The value of services or facilities furnished by a governmental unit to the organization without charge..            
4 Total. Add lines 1 through 3.. 246,772,831 256,914,242 269,310,797 238,864,532 271,052,399 1,282,914,801
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f)..           32,756,803
6 Public Support. Subtract line 5 from line 4.           1,250,157,998
Section B. Total Support
Calendar year(or fiscal year beginning in) (a) 2006 (b) 2007 (c) 2008 (d) 2009 (e) 2010 (f) Total
7 Amounts from line 4.. 246,772,831 256,914,242 269,310,797 238,864,532 271,052,399 1,282,914,801
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. 6,538,216 7,451,748 6,950,554 4,962,639 3,145,637 29,048,794
9 Net income from unrelated business activities, whether or not the business is regularly carried on..            
10 Other income. (Explain in Part IV.) Do not include gain or loss from the sale of capital assets.. 1,446,752 1,098,580 2,816,918 1,925,834 1,779,485 9,067,569
11 Total support (Add lines 7 through 10).           1,321,031,164
12
12
192,137,673
13
Section C. Computation of Public Support Percentage
14
14
94.640 %
15
15
96.910 %
16a
b
17a
b
18
Schedule A (Form 990 or 990-EZ) 2010
Schedule A (Form 990 or 990-EZ) 2010
Page 3
Part III
Support Schedule for Organizations Described in IRC 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year(or fiscal year beginning in) (a) 2006 (b) 2007 (c) 2008 (d) 2009 (e) 2010 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......            
3 Gross receipts from activities that are not an unrelated trade or business under section 513..            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge..            
6 Total. Add lines 1 through 5.            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons...            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public Support (Subtract line 7c from line 6.)            
Section B. Total Support
Calendar year (or fiscal year beginning in) (a) 2006 (b) 2007 (c) 2008 (d) 2009 (e) 2010 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)            
13 Total support (Add lines 9, 10c, 11 and 12.).            
14
Section C. Computation of Public Support Percentage
15
15
 
16
16
 
Section D. Computation of Investment Income Percentage
17
17
 
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2010
Schedule A (Form 990 or 990-EZ) 2010
Page 4
Part IV
Supplemental Information. Supplemental Information. Complete this part to provide the explanation required by Part II, line 10; Part II, line 17a or 17b; or Part III, line 12. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Explanation
 
 
 
 
Schedule A (Form 990 or 990-EZ) 2010

Additional Data


Software ID:  
Software Version:  
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors
Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
OMB No. 1545-0047
2010
Name of organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ





Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule—
Special Rules
......................... Arrow Bullet   $    
Caution. An Organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2 of its Form 990, or check the box in the heading of its
Form 990-EZ, or on line 2 of its Form 990-PF, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2010)

Schedule B (Form 990, 990-EZ, or 990-PF) (2010)
Page 1 of 1 of Part I
Name of organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC 		Employer identification number

13-5644916
Part I
Contributors (see Instructions)
     
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
RESTRICTED
RESTRICTED
 

     
RESTRICTED
RESTRICTED  
RESTRICTED, RESTRICTED   RESTRICTED

$RESTRICTED




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Aggregate contributions		 (d)
Type of contribution
 
 
 

     
 
   

$  




(Complete Part II if there is
a noncash contribution.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2010)

Schedule B (Form 990, 990-EZ, or 990-PF) (2010)
Page 1 of 1 of Part II
Name of organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC 		Employer identification number

13-5644916
Part II
Noncash Property (see Instructions)
     
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2010)

Schedule B (Form 990, 990-EZ, or 990-PF) (2010)
Page 1 of 1 of Part III
Name of organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC 		Employer identification number

13-5644916
Part III
Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
aggregating more than $1,000 for the year. (Complete columns (a) through (e) and the following line entry.)
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet $  
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
(a) No.
from
Part I		 (b)
Purpose of gift		 (c)
Use of gift		 (d)
Description of how gift is held
 
(e)
Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
       
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2010)

Additional Data


Software ID:  
Software Version:  
SCHEDULE C
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Political Campaign and Lobbying Activities

For Organizations Exempt From Income Tax Under section 501(c) and section 527
SchCMd Bullet Complete if the organization is described below.
SchCMd Bullet Attach to Form 990 or Form 990-EZ. SchCMd Bullet See separate instructions.
OMB No. 1545-0047
2010
Open to Public
Inspection
If the organization answered “Yes,” to Form 990, Part IV, Line 3, or Form 990-EZ, Part V, line 46 (Political Campaign Activities), then
Round Bullet Section 501(c)(3) organizations: Complete Parts I-A and B. Do not complete Part I-C.
Round Bullet Section 501(c) (other than section 501(c)(3)) organizations: Complete Parts I-A and C below. Do not complete Part I-B.
Round Bullet Section 527 organizations: Complete Part I-A only.
If the organization answered “Yes,” to Form 990, Part IV, Line 4, or Form 990-EZ, Part VI, line 47 (Lobbying Activities), then
Round Bullet Section 501(c)(3) organizations that have filed Form 5768 (election under section 501(h)) Complete Part II-A. Do not complete Part II-B.
Round Bullet Section 501(c)(3) organizations that have NOT filed Form 5768 (election under section 501(h)): Complete Part II-B. Do not complete Part II-A.
If the organization answered “Yes,” to Form 990, Part IV, Line 5 (Proxy Tax) or Form 990-EZ, Part V, line 35a (Proxy Tax), then
Round Bullet Section 501(c)(4), (5), or (6) organizations: Complete Part III.
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I-A
Complete if the organization is exempt under section 501(c) or is a section 527 organization.

1
Provide a description of the organization's direct and indirect political campaign activities on behalf of or in opposition to candidates for public office in Part IV.
2
Political expenditures ....................................SchCMd Bullet
$  
3
Volunteer hours ........................................
 

Part I-B
Complete if the organization is exempt under section 501(c)(3).
1
Enter the amount of any excise tax incurred by the organization under section 4955 .........SchCMd Bullet
$  
2
Enter the amount of any excise tax incurred by organization managers under section 4955 ......SchCMd Bullet
$  
3
If the organization incurred a section 4955 tax, did it file Form 4720 for this year? ..............
4a
Was a correction made? .........................................
b
If "Yes," describe in Part IV.
Part I-C
Complete if the organization is exempt under section 501(c) except section 501(c)(3).
1
Enter the amount directly expended by the filing organization for section 527 exempt function activities SchCMd Bullet
$  
2
Enter the amount of the filing organization's funds contributed to other organizations for section 527 exempt funtion activities ....................................SchCMd Bullet

$  
3
Total exempt function expenditures. Add lines 1 and 2. Enter here and on Form 1120-POL, line 17b..SchCMd Bullet

$  
4
Did the filing organization file Form 1120-POL for this year? ..........................
5
Enter the names, addresses and employer identification number (EIN) of all section 527 political organizations to which the filing
organization made payments. For each organization listed, enter the amount paid from the filing organization’s funds. Also enter the amount of political contributions received that were promptly and directly delivered to a separate political organization, such as a separate segregated fund or a political action committee (PAC). If additional space is needed, provide information in Part IV.
(a) Name (b) Address (c) EIN (d) Amount paid from filing organization's funds. If none, enter -0-. (e) Amount of political contributions received and promptly and directly delivered to a separate political organization. If none, enter -0-.










For Privacy Act and Paperwork Reduction Act Notice, see the instructions for Form 990.
Cat. No. 50084S
Schedule C (Form 990 or 990-EZ) 2010

Schedule C (Form 990 or 990-EZ) 2010
Page 2
Part II-A
Complete if the organization is exempt under section 501(c)(3) and filed Form 5768 (election under section 501(h)).
A Check
B Check
Limits on Lobbying Expenditures
(The term "expenditures" means amounts paid or incurred.) 		(a) Filing
Organization's
Totals 		(b) Affiliated Group
Totals
1a Total lobbying expenditures to influence public opinion (grass roots lobbying) ......    
b Total lobbying expenditures to influence a legislative body (direct lobbying) .......    
c Total lobbying expenditures (add lines 1a and 1b) ...................    
d Other exempt purpose expenditures ........................    
e Total exempt purpose expenditures (add lines 1c and 1d) ...............    
f Lobbying nontaxable amount. Enter the amount from the following table in both
columns.		    
  If the amount on line 1e, column (a) or (b) is:The lobbying nontaxable amount is:    
  Not over $500,00020% of the amount on line 1e.    
  Over $500,000 but not over $1,000,000$100,000 plus 15% of the excess over $500,000.    
  Over $1,000,000 but not over $1,500,000$175,000 plus 10% of the excess over $1,000,000.    
  Over $1,500,000 but not over $17,000,000$225,000 plus 5% of the excess over $1,500,000.    
  Over $17,000,000$1,000,000.    
       
g Grassroots nontaxable amount (enter 25% of line 1f) .................    
h Subtract line 1g from line 1a. If zero or less, enter -0-. ................    
i Subtract line 1f from line 1c. If zero or less, enter -0-. ................    
j If there is an amount other than zero on either line 1h or line 1i, did the organization file Form 4720 reporting
section 4911 tax for this year? ......................................

4-Year Averaging Period Under Section 501(h)
(Some organizations that made a section 501(h) election do not have to complete all of the five
columns below. See the instructions for lines 2a through 2f on page 4.)
Lobbying Expenditures During 4-Year Averaging Period
  Calendar year (or fiscal year
beginning in) 		(a) 2007 (b) 2008 (c) 2009 (d) 2010 (e) Total
             
2a Lobbying non-taxable amount          
             
b Lobbying ceiling amount
(150% of line 2a, column(e)) 		         
             
c Total lobbying expenditures          
             
d Grassroots non-taxable amount          
             
e Grassroots ceiling amount
(150% of line 2d, column (e))		          
             
f Grassroots lobbying expenditures          
Schedule C (Form 990 or 990-EZ) 2010


Schedule C (Form 990 or 990-EZ) 2010
Page 3
Part II-B
Complete if the organization is exempt under section 501(c)(3) and has NOT filed Form 5768 (election under section 501(h)).
(a)
Yes
No
(b)
Amount
1
During the year, did the filing organization attempt to influence foreign, national, state or local legislation, including any attempt to influence public opinion on a legislative matter or referendum, through the use of:
a
Volunteers? .........................................
Yes
 
b
Paid staff or management (include compensation in expenses reported on lines 1c through 1i)? ....
Yes
 
c
Media advertisements? ....................................
 
No
 
d
Mailings to members, legislators, or the public? .........................
Yes
 
30,000
e
Publications, or published or broadcast statements? .......................
Yes
 
8,000
f
Grants to other organizations for lobbying purposes? .......................
 
No
 
g
Direct contact with legislators, their staffs, government officials, or a legislative body? ........
Yes
 
 
h
Rallies, demonstrations, seminars, conventions, speeches, lectures, or any similar means? ......
Yes
 
110,000
i
Other activities? If "Yes," describe in Part IV ..........................
Yes
 
16,800
j
Total. lines 1c through 1i ...................................
164,800
2a
Did the activities in line 1 cause the organization to be not described in section 501(c)(3)? .....
 
No
b
If "Yes," enter the amount of any tax incurred under section 4912 .................
 
c
If "Yes," enter the amount of any tax incurred by organization managers under section 4912 .....
 
d
If the filing organization incurred a section 4912 tax, did it file Form 4720 for this year? .......
 
No
Part III-A
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6).
Yes
No
1
Were substantially all (90% or more) dues received nondeductible by members? ................
1
 
No
2
Did the organization make only in-house lobbying expenditures of $2,000 or less? ................
2
 
No
3
Did the organization agree to carryover lobbying and political expenditures from the prior year? ..........
3
 
No
Part III-B
Complete if the organization is exempt under section 501(c)(4), section 501(c)(5), or section 501(c)(6) if BOTH Part III-A, lines 1 and 2 are answered “No” OR if Part III-A, line 3 is answered “Yes”.
1
Dues, assessments and similar amounts from members .....................
1
 
2
Section 162(e) non-deductible lobbying and political expenditures (do not include amounts of political
expenses for which the section 527(f) tax was paid).
a
Current year .........................................
2a
 
b
Carryover from last year ....................................
2b
 
c
Total ...........................................
2c
 
3
Aggregate amount reported in section 6033(e)(1)(A) notices of nondeductible section 162(e) dues .
3
 
4
If notices were sent and the amount on line 2c exceeds the amount on line 3, what portion of the excess does the organization agree to carryover to the reasonable estimate of nondeductible lobbying and political expenditure next year? ................................
4
 
5
Taxable amount of lobbying and political expenditures (see instructions) ..............
5
 
Part IV
Supplemental Information
Complete this part to provide the descriptions required for Part l-A, line 1; Part l-B, line 4; Part l-C, line 5; and Part ll-B, line 1i.
Also, complete this part for any additional information.
Identifier Return Reference Explanation
  SCHEDULE C, PART II-B, LINE 1I LLS IS A MEMBER OF A NUMBER OF COALITIONS INCLUDING RESEARCH AMERICA, ONE VOICE AGAINST CANCER, NATIONAL COALITION FOR CANCER RESEARCH,COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH, AND ALLIANCE FOR A STRONGER FDA.
Schedule C (Form 990 or 990EZ) 2010

Additional Data


Software ID:  
Software Version:  

SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11, or 12.
SchDMd Bullet Attach to Form 990. SchDMd Bullet See separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .......    
2 Aggregate contributions to (during year) ...    
3 Aggregate grants from (during year) ...    
4 Aggregate value at end of year .......    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds may be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit. ...................................
Part II
Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a–2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ....................... 2a  
b Total acreage restricted by conservation easements .................. 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 8/17/06 ........ 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the taxable year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................
6
Staff and volunteer hours devoted to monitoring, inspecting and enforcing conservation easements during the year SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section
170(h)(4)(B)(i) and 170(h)(4)(B)(ii)? ....................................
9
In Part XIV, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under SFAS 116, not to report in its revenue statement and balance sheet works of
art, historical treasures, or other similar assets held for public exhibition, education or research in furtherance of public service,
provide, in Part XIV, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under SFAS 116, to report in its revenue statement and balance sheet works of art,
historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service,
provide the following amounts relating to these items:
(i)
Revenues included in Form 990, Part VIII, line 1 ........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ..............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 relating to these items:
a
Revenues included in Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Privacy Act and Paperwork Reduction Act Notice, see the Intructions for Form 990
Cat. No. 52283D
Schedule D (Form 990) 2010

Schedule D (Form 990) 2010
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s accession and other records, check any of the following that are a significant use of its collection
items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIV.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b
If "Yes," explain the arrangement in Part XIV and complete the following table:
Amount
c Beginning balance ................................. 1c  
d Additions during the year .............................. 1d  
e Distributions during the year ............................. 1e  
f Ending balance ................................... 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21? .....................
b
If “Yes,” explain the arrangement in Part XIV.
Part V
Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.
(a)Current Year (b)Prior Year (c)Two Years Back (d)Three Years Back (e)Four Years Back
1a Beginning of year balance .... 5,023,902 4,481,610 5,228,375
b Contributions ........ 111,064    
c Investment earnings or losses ... 938,068 563,236 -730,333
d Grants or scholarships .....      
e Other expenditures for facilities
and programs ........ 		     
f Administrative expenses .... -13,040 -20,944 -16,432
g End of year balance ...... 6,059,994 5,023,902 4,481,610
2
Provide the estimated percentage of the year end balance held as:
a
Board designated or quasi-endowment: SchDMd Bullet  
b
Permanent endowment: SchDMd Bullet54.000 %
c
Term endowment: SchDMd Bullet46.000 %
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) unrelated organizations ........................
3a(i)
 
No
(ii) related organizations ........................
3a(ii)
 
No
b
If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
No
4
Describe in Part XIV the intended uses of the organization's endowment funds.
Part VI
Investments—Land, Buildings, and Equipment. See Form 990, Part X, line 10.
Description of investment (a) Cost or other basis (investment) (b)Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .................      
b Buildings ................        
c Leasehold improvements ............   838,350 657,891 180,459
d Equipment ................   6,909,271 4,369,616 2,539,655
e Other .................   5,893,104 3,430,909 2,462,195
Total. Add lines 1a-1e. (Column (d) should equal Form 990, Part X, column (B), line 10(c).)........SchDMdBullet 5,182,309
Schedule D (Form 990) 2010

Schedule D (Form 990) 2010
Page 3
Part VII
Investments—Other Securities. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b)Book value (c) Method of valuation:
Cost or end-of-year market value
(1)Financial derivatives    
(2)Closely-held equity interests    
(3)Other
(A) FUND OF HEDGE FUNDS-OPERATING 		34,424,715 F

(B) LIMITED PARTNERSHIP INDICIES-OPERATI 		14,138,404 F

(C) FUND OF HEDGE FUNDS-ENDOWMENT 		1,020,502 F

(D) LIMITED PARTNERSHIP INDICIES-ENDOWME 		996,514 F

(E) PRINCIPAL 457B PLAN 		973,348 F




Total. (Column (b) should equal Form 990, Part X, col.(B) line 12.)Small Bullet 51,553,483
Part VIII
Investments—Program Related. See Form 990, Part X, line 13.
(a) Description of investment type (b) Book value (c) Method of valuation:
Cost or end-of-year market value








Total. (Column (b) should equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets. See Form 990, Part X, line 15.
(a) Description (b) Book value








Total. (Column (b) should equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities. See Form 990, Part X, line 25.
1.(a) Description of Liability (b) Amount
Federal Income Taxes  








Total. (Column (b) should equal Form 990, Part X, col.(B) line 25.)Small Bullet  
2. Fin 48 (ASC 740) Footnote. In Part XIV, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC740).
Schedule D (Form 990) 2010

Schedule D (Form 990) 2010
Page 4
Part XI Reconciliation of Change in Net Assets from Form 990 to Financial Statements
1 Total revenue (Form 990, Part VIII, column (A), line 12) .................... 1 283,832,501
2 Total expenses (Form 990, Part IX, column (A), line 25) ..................... 2 280,841,124
3 Excess or (deficit) for the year. Subtract line 2 from line 1 ............. 3 2,991,377
4 Net unrealized gains (losses) on investments .......................... 4 7,272,440
5 Donated services and use of facilities ............................. 5  
6 Investment expenses ................................... 6  
7 Prior period adjustments .................................. 7  
8 Other (Describe in Part XIV) ................................. 8 168,183
9 Total adjustments (net). Add lines 4 - 8 ............................. 9 7,440,623
10 Excess or (deficit) for the year per financial statements. Combine lines 3 and 9 ......... 10 10,432,000
Part XII Reconciliation of Revenue per Audited Financial Statements With Revenue per Return
1 Total revenue, gains, and other support per audited financial statements ....... 1 309,187,000
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains on investments .......... 2a 7,272,440
b Donated services and use of facilities ......... 2b 5,982,875
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIV): ............ 2d 12,800,724
e Add lines 2a through 2d ..................... 2e 26,056,039
3 Subtract line 2e from line 1..................... 3 283,130,961
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a 701,540
b Other (Describe in Part XIV): ........... 4b  
c Add lines 4a and 4b....................... 4c 701,540
5 Total Revenue. Add lines 3 and 4c. (This should equal Form 990, Part I, line 12.) ...... 5 283,832,501
Part XIII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return
1 Total expenses and losses per audited financial statements ............. 1 299,075,000
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities .......... 2a 5,982,875
b Prior year adjustments .............. 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIV): ............ 2d 12,952,541
e Add lines 2a through 2d...................... 2e 18,935,416
3 Subtract line 2e from line 1..................... 3 280,139,584
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a 701,540
b Other (Describe in Part XIV): ............ 4b  
c Add lines 4a and 4b....................... 4c 701,540
5 Total expenses. Add lines 3 and 4c. (This should equal Form 990, Part I, line 18.) ...... 5 280,841,124
Part XIV
Supplemental Information
Complete this part to provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X; Part XI, line 8; Part XII, lines 2d and 4b; and Part XIII, lines 2d and 4b. Also complete this part to provide any additional information.
Identifier Return Reference Explanation
COLLECTIONS AND RELATION TO EXEMPT PURPOSE SCHEDULE D, PAGE 2, PART III, LINE 4 THE LLS'S COLLECTION IS OF PHOTOGRAPHS WHICH ARE USED FOR PUBLIC EXHIBITION AT FUNDRAISING EVENTS HELD TO SUPPORT LLS'S PROGRAMS.
INTENDED USES FOR ENDOWMENT FUNDS SCHEDULE D, PAGE 2, PART V, LINE 4 LLS'S ENDOWMENTS ARE INTENDED TO FUND RESEARCH AS WELL AS SUPPORT LLS'S PUBLIC EDUCATION PROGRAMS.
LIABILITY UNDER FIN 48 FOOTNOTE SCHEDULE D, PAGE 3, PART X LLS RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY OF THOSE TAX POSITIONS THAT ARE MORE LIKELY THAN NOT TO BE SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO LLS'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. LLS DID NOT RECOGNIZE ANY UNRELATED INCOME TAX LIABILITY FOR THE YEARS ENDED JUNE 30, 2011 AND 2010.
RECONCILIATION OF CHANGES - OTHER SCHEDULE D, PAGE 4, PART XI, LINE 8 LSRP OTHER REVENUE 35,116 LLS CANADA REVENUE 12,766,323 ROUNDING FOR AUDITED STATEMENTS -715 LSRP EXPENSES -1,511 LLS CANADA EXPENSES -12,949,776 ROUNDING FOR AUDITED STATEMENTS -1,254
REVENUE AMOUNTS INCLUDED IN FINANCIALS - OTHER SCHEDULE D, PAGE 4, PART XII, LINE 2D LSRP OTHER REVENUE 35,116 LLS CANADA REVENUE 12,766,323 ROUNDING FOR AUDITED STATEMENTS -715
EXPENSE AMOUNTS INCLUDED IN FINANCIALS - OTHER SCHEDULE D, PAGE 4, PART XIII, LINE 2D LSRP EXPENSES 1,511 LLS CANADA EXPENSES 12,949,776 ROUNDING FOR AUDITED STATEMENTS 1,254
SUPPLEMENTAL FINANCIAL INFORMATION SCHEDULE D, PAGE 4, PART XIV PART III, LINE 1A: THE LEUKEMIA & LYMPHOMA SOCIETY MAINTAINS A SMALL PHOTOGRAPH COLLECTION FOR PUBLIC EXHIBITION WHICH HAS AN ESTIMATED VALUE BETWEEN 20,000 AND 50,000. AS THIS REPRESENTS A RELATIVELY SMALL PERCENTAGE OF LLS'S ASSETS, IT IS NOT SEPARATELY DISCLOSED IN THE FINANCIAL STATEMENTS OR FOOTNOTES.
Schedule D (Form 990) 2010

Additional Data


Software ID:  
Software Version:  




SCHEDULE F
(Form 990)

Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990,
Part IV, line 14b, 15, or 16.
Right pointing arrow large image Attach to Form 990. Right pointing arrow large image See separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I
General Information on Activities Outside the United States. Complete if the organization answered
“Yes” to Form 990, Part IV, line 14b.
1
For grantmakers. Does the organization maintain records to substantiate the amount of the grants or
assistance, the grantees' eligibility for the grants or assistance, and the selection criteria used to award
the grants or assistance? ...................................
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of grant funds outside the
United States.
3
Activites per Region. (Use Part V if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees or agents in region or independent contractors (d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in region		 (f) Total
expenditures for region/investments
in region
EAST ASIA 2 2 RESEARCH FUNDING RESEARCH GRANTS 300,000
MIDDLE EAST 1 1 RESEARCH FUNDING RESEARCH GRANTS 200,000
EUROPE 8 8 RESEARCH FUNDING RESEARCH GRANTS 1,949,500
NORTH AMERICA 18 18 RESEARCH FUNDING RESEARCH GRANTS 2,338,626
CENTRAL AMERICA & THE CARIBBEAN 1 1 INVESTMENTS INVESTMENTS 16,736,363
           
           
           
           
           
           
           
           
           
           
           
           
3a Sub-total ..... 30 30 21,524,489
b Total from continuation sheets to Part I ...      
c Totals (add lines 3a and 3b) 30 30 21,524,489
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2010
Schedule F (Form 990) 2010
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990,
Part IV, line 15, for any recipient who received more than $5,000. Check this box if no one recipient received more than $5,000 ........ MediumBullet
Use Part V if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount of
of non-cash
assistance 		(h) Description
of non-cash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
EAST ASIA & PACIFIC RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 110,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 65,000 CHECK     ACCRUAL
MIDDLE EAST & NORTH AFRICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 110,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 65,000 CHECK     ACCRUAL
EAST ASIA & PACIFIC RESEARCH GRANT 100,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 1,250,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA THERAPY ACCELERATION 307,026 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 112,977 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 75,000 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 48,436 CHECK     FMV
EUROPE THERAPY ACCELERATION 14,500 CHECK     FMV
EAST ASIA & PACIFIC RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 110,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
NORTH AMERICA RESEARCH GRANT 65,000 CHECK     ACCRUAL
MIDDLE EAST & NORTH AFRICA RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 110,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 65,000 CHECK     ACCRUAL
EAST ASIA & PACIFIC RESEARCH GRANT 100,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 200,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 1,250,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
EUROPE RESEARCH GRANT 55,000 CHECK     ACCRUAL
NORTH AMERICA THERAPY ACCELERATION 307,026 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 112,977 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 75,000 CHECK     FMV
NORTH AMERICA THERAPY ACCELERATION 48,436 CHECK     FMV
EUROPE THERAPY ACCELERATION 14,500 CHECK     FMV
2
Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter .....MediumBullet
 
3
Enter total number of other organizations or entities ........................MediumBullet
29
Schedule F (Form 990) 2010
Schedule F (Form 990) 2010Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.
Use Part V if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
non-cash
assistance 		(g) Description
of non-cash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2010
Schedule F (Form 990) 2010
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 926 (see instructions for Form 926).................
2 Did the organization have an interest in a foreign trust during the tax year? If " Yes," the organization may be required to file Form 3520 and/or Form 3520-A. (see instructions for Forms 3520 and 3520-A)..........
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with respect to Certain Foreign Corporations. (see instructions for Form 5471)..............................
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If "Yes," the organization may be required to file Form 8621, Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see instructions for Form 8621)
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with respect to Certain Foreign Partnerships. (see instructions for Form 8865)....................................
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see instructions for Form 5713)................................................
Schedule F (Form 990) 2010
Schedule F (Form 990) 2010
Page 5
Part V
Supplemental Information
Complete this part to provide the information (see instructions) required in Part I, line 2, and any additional information.
Identifier ReturnReference Explanation
PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS OUTSIDE THE UNITED STATES SCHEDULE F, PAGE 1, PART I, LINE 2 FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS,EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT.
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
Schedule F (Form 990) 2010
Additional Data


Software ID:  
Software Version:  



SCHEDULE G
(Form 990 or 990-EZ)
Department of the Treasury
Internal Revenue Service
Supplemental Information Regarding
Fundraising or Gaming Activities
Complete if the organization answered "Yes" to Form 990, Part IV, lines 17, 18, or 19,
or if the organization entered more than $15,000 on Form 990-EZ, line 6a.
right arrow Attach to Form 990 or Form 990-EZ. right arrow See separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I
Fundraising Activities. Complete if the organization answered "Yes" to Form 990, Part IV, line 17.
1
Indicate whether the organization raised funds through any of the following activities. Check all that apply.
a e
b f
c g
d
2a
Did the organization have a written or oral agreement with any individual (including officers, directors, trustees
or key employees listed in Form 990, Part VII) or entity in connection with professional fundraising services?
b
If “Yes,” list the ten highest paid individuals or entities (fundraisers) pursuant to agreements under which the fundraiser is
to be compensated at least $5,000 by the organization. Form 990-EZ filers are not required to complete this table.
(i) Name and address of individual
or entity (fundraiser) 		(ii) Activity (iii) Did fundraiser have custody or control of contributions? (iv) Gross receipts
from activity 		(v) Amount paid to
(or retained by)
fundraiser listed in
col. (i) 		(vi) Amount paid to
(or retained by)
organization
Yes No
PARADYZ DIRECT
5 HANOVER SQUARE
SIXTH FLOOR
NEW YORK, NY10004 		DIRECT MAI   No   3,852,425 -3,852,425
DIRECT PRINT COMMUNICATIONS
201 EAST SANDPOINTE
SUITE 400
SANTA ANA, CA92707 		DIRECT MAI   No   2,515,663 -2,515,663
INFOCISION
325 SPRINGSIDE DRIVE
 
AKRON, OH44333 		TELEMARKET   No   2,210,192 -2,210,192
THOMPSON HABIB DENISON
80 HAYDEN AVENUE
SUITE 300
LEXINGTON, MA02421 		DIRECT MAI   No   605,325 -605,325
HANINES COMPANY
8050 FREEDOM AVENUE
 
CANTON, OH44720 		TELEMARKET   No   417,716 -417,716
PIDIBLACKBAUD
1800 DIAGONAL RAOD
SUITE 400
ALEXANDRIA, VA22314 		DIRECT MAI   No   209,505 -209,505
Total .................right arrow   9,810,826  
3
List all states in which the organization is registered or licensed to solicit funds or has been notified it is exempt from registration or licensing.
All States
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50083H
Schedule G (Form 990 or 990-EZ) 2010
Schedule G (Form 990 or 990-EZ) 2010
Page 2
Part II
Fundraising Events. Complete if the organization answered "Yes" to Form 990, Part IV, line 18, or reported more than $15,000 on Form 990-EZ, line 6a. List events with gross receipts greater than $5,000.
(a) Event #1

NIKE WOMENS MAR
(event type) 		(b) Event #2

ROCK N ROLL MAR
(event type) 		(c) Other Events

720
(total number) 		(d) Total Events
(Add col. (a) through col. (c))
VerticalRevenue 1 Gross receipts . . . 11,111,394 8,301,245 171,840,439 191,253,078
2 Less: Charitable
contributions . . . 		8,308,343 5,723,636 140,809,016 154,840,995
3 Gross income (line 1
minus line 2) . . . 		2,803,051 2,577,609 31,031,423 36,412,083
VerticalDirectExpenses 4 Cash prizes . . .        
5 Non-cash prizes . .        
6 Rent/facility costs . .        
7 Food and beverages . .        
8 Entertainment . . .        
9 Other direct expenses . 2,803,051 2,577,609 31,031,423 36,412,083
10 Direct expense summary. Add lines 4 through 9 in column (d) ........... right arrow 36,412,083
11 Net income summary. Combine lines 3 and 10 in column (d)............ right arrow  
Part III
Gaming. Complete if the organization answered "Yes" to Form 990, Part IV, line 19, or reported more than $15,000 on Form 990-EZ, line 6a.
VerticalRevenue (a) Bingo (b) Pull tabs/Instant
bingo/progressive bingo 		(c) Other gaming (d) Total gaming (Add col. (a) through col. (c))
1 Gross revenue . . . .     738,168 738,168
VerticalDirectExpenses 2 Cash prizes . . . .     8,615 8,615
3 Non-cash prizes . . .     38,437 38,437
4 Rent/facility costs . . .        
5 Other direct expenses . .     3,638 3,638
6 Volunteer labor . . .
 
 
6.000 %
7 Direct expense summary. Add lines 2 through 5 in column (d) ........... right arrow 50,690
8 Net gaming income summary. Combine lines 1 and 7 in column (d) .......... right arrow 687,478
9
Enter the state(s) in which the organization operates gaming activities: AK , AZ , CA , CT , DC , FL , GA , LA , MA , MD , MI , MN , MS , NJ , NV , NY , OH , PA , RI , TX , VA , WA , WI
a
Is the organization licensed to operate gaming activities in each of these states? ............
b
If "No," Explain:
 
10a
Were any of the organization's gaming licenses revoked, suspended or terminated during the tax year? .....
b
If "Yes," Explain:
 
11
Does the organization operate gaming activities with nonmembers? .................
12
Is the organization a grantor, beneficiary or trustee of a trust or a member of a partnership or other entity
formed to administer charitable gaming? ...........................
Schedule G (Form 990 or 990-EZ) 2010
Schedule G (Form 990 or 990-EZ) 2010
Page 3
13
Indicate the percentage of gaming activity operated in:
a
The organization's facility ......................
13a
 
b
An outside facility ........................
13b
100.000 %
14
Provide the name and address of the person who prepares the organization's gaming/special events books and records:
Name right arrow
JAMES T NANGLE
Address right arrow
1311 MAMARONECK AVENUE
WHITE PLAINS,NY10605
15a
Does the organization have a contract with a third party from whom the organization receives gaming
revenue? ......................................
b
If "Yes," enter the amount of gaming revenue received by the organization right arrow $   and the
amount of gaming revenue retained by the third party right arrow $   .
c
If "Yes," enter name and address:
Name right arrow
Address right arrow
 
 
16
Gaming manager information:
Name right arrow
Gaming manager compensation right arrow $  
Description of services provided right arrow
 
17
Mandatory distributions:
a
Is the organization required under state law to make charitable distributions from the gaming proceeds to
retain the state gaming license? ............................
b
Enter the amount of distributions required under state law distributed to other exempt organizations or spent
in the organization's own exempt activities during the tax year right arrow$  
Part IV
Complete this part to provide additional information for responses to quuestion on Schedule G (see instructions.)
Identifier ReturnReference Explanation
STATES WITH GAMING OPERATIONS SCHEDULE G PAGE 2 PART III LINE 9 ALASKA ARIZONA CALIFORNIA CONNECTICUT DIST OF COLUMBIA FLORIDA GEORGIA LOUISIANA MASSACHUSETTS MARYLAND MICHIGAN MINNESOTA MISSISSIPPI NEW JERSEY NEVADA NEW YORK OHIO PENNSYLVANIA RHODE ISLAND TEXAS VIRGINIA WASHINGTON WISCONSIN
    SCHEDULE G PART I LINE 2B LLS USED INFOCISION HAINES CO AND THOMPSON HABIB DENISON FOR ITS NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMSTHESE PROGRAMS GENERATED GROSS RECEIPTS OF 31409474 DURING FISCAL YEAR 2011 LLS USED DIRECT PRINT COMMUNICATIONS PARADYSZ MATERA AND PIDIBLACKBAUD FOR ALL OF ITS OTHER FUNDRAISING EVENTS
Schedule G (Form 990 or 990-EZ) 2010
Additional Data


Software ID:  
Software Version:  
Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990
OMB No. 1545-0047
2010
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number
13-5644916
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21 for any recipient that received more than $5,000. Check this box if no one recipient received more than $5,000. Use
Part IV and Schedule I-1 (Form 990) if additional space is needed ......................... lBullet
(a) Name and address of organization
or government		 (b) EIN (c) IRC Code section
if applicable		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
non-cash assistance		 (h) Purpose of grant
or assistance
(1) MAYO CLINIC ARIZONA DBA MAYO CLI
MAYO CLINIC ARIZONA D/B/A MAYO CLI13400 EAST SHEA BOULEVARD
13400 EAST SHEA BOULEVARD
SCOTTSDALE,AZ85250 		86-0800150 3 200,000   ACCRUAL   RESEARCH GRANT
(2) BECKMAN RESEARCH INSTITUTE OF THE C
BECKMAN RESEARCH INSTITUTE OF THE C1500 EAST DUARTE ROAD
1500 EAST DUARTE ROAD
DUARTE,CA91010 		95-3432210 3 200,000   ACCRUAL   RESEARCH GRANT
(3) BECKMAN RESEARCH INSTITUTE OF THE C
BECKMAN RESEARCH INSTITUTE OF THE C1500 EAST DUARTE ROAD
1500 EAST DUARTE ROAD
DUARTE,CA91010 		95-3432210 3 200,000   ACCRUAL   RESEARCH GRANT
(4) BECKMAN RESEARCH INSTITUTE OF THE C
BECKMAN RESEARCH INSTITUTE OF THE C1500 EAST DUARTE ROAD
1500 EAST DUARTE ROAD
DUARTE,CA91010 		95-3432210 3 200,000   ACCRUAL   RESEARCH GRANT
(5) LA JOLLA INSTITUTE FOR ALLERGY & IM
LA JOLLA INSTITUTE FOR ALLERGY & IM9420 ATHENA CIRCLE
9420 ATHENA CIRCLE
LA JOLLA,CA92037 		33-0328688 3 65,000   ACCRUAL   RESEARCH GRANT
(6) LA JOLLA INSTITUTE FOR ALLERGY & IM
LA JOLLA INSTITUTE FOR ALLERGY & IM9420 ATHENA CIRCLE
9420 ATHENA CIRCLE
LA JOLLA,CA92037 		33-0328688 3 200,000   ACCRUAL   RESEARCH GRANT
(7) LA JOLLA INSTITUTE FOR ALLERGY & IM
LA JOLLA INSTITUTE FOR ALLERGY & IM9420 ATHENA CIRCLE
9420 ATHENA CIRCLE
LA JOLLA,CA92037 		33-0328688 3 65,000   ACCRUAL   RESEARCH GRANT
(8) STANFORD UNIVERSITY
STANFORD UNIVERSITY9500 GILMAN DRIVE
9500 GILMAN DRIVE
LA JOLLA,CA92037 		23-7121131 3 65,000   ACCRUAL   RESEARCH GRANT
(9) THE SALK INSTITUTE FOR BIOLOGICAL S
THE SALK INSTITUTE FOR BIOLOGICAL S10010 NORTH TORREY PINES ROAD
10010 NORTH TORREY PINES ROAD
LA JOLLA,CA92037 		95-2160097 3 55,000   ACCRUAL   RESEARCH GRANT
(10) THE SCRIPPS RESEARCH INSTITUTE
THE SCRIPPS RESEARCH INSTITUTE10550 NORTH TORREY PINES ROAD
10550 NORTH TORREY PINES ROAD
LA JOLLA,CA92037 		33-0435954 3 110,000   ACCRUAL   RESEARCH GRANT
(11) THE SCRIPPS RESEARCH INSTITUTE
THE SCRIPPS RESEARCH INSTITUTE10550 NORTH TORREY PINES ROAD
10550 NORTH TORREY PINES ROAD
LA JOLLA,CA92037 		33-0435954 3 55,000   ACCRUAL   RESEARCH GRANT
(12) THE SCRIPPS RESEARCH INSTITUTE
THE SCRIPPS RESEARCH INSTITUTE10550 NORTH TORREY PINES ROAD
10550 NORTH TORREY PINES ROAD
LA JOLLA,CA92037 		33-0435954 3 110,000   ACCRUAL   RESEARCH GRANT
(13) UNIVERSITY OF CALIFORNIA SAN DIEGO
UNIVERSITY OF CALIFORNIA SAN DIEGO9500 GILMAN DRIVE
9500 GILMAN DRIVE
LA JOLLA,CA92037 		95-6006144 3 110,000   ACCRUAL   RESEARCH GRANT
(14) UNIVERSITY OF CALIFORNIA SAN DIEGO
UNIVERSITY OF CALIFORNIA SAN DIEGO9500 GILMAN DRIVE
9500 GILMAN DRIVE
LA JOLLA,CA92037 		95-6006144 3 55,000   ACCRUAL   RESEARCH GRANT
(15) UNIVERSITY OF CALIFORNIA SAN DIEGO
UNIVERSITY OF CALIFORNIA SAN DIEGO9500 GILMAN DRIVE
9500 GILMAN DRIVE
LA JOLLA,CA92037 		95-6006144 3 65,000   ACCRUAL   RESEARCH GRANT
(16) CHILDRENS HOSPITAL LOS ANGELES
CHILDRENS HOSPITAL LOS ANGELES4650 SUNSET BLVD
4650 SUNSET BLVD
LOS ANGELES,CA90001 		95-1690977 3 200,000   ACCRUAL   RESEARCH GRANT
(17) CHILDRENS HOSPITAL LOS ANGELES
CHILDRENS HOSPITAL LOS ANGELES4650 SUNSET BLVD
4650 SUNSET BLVD
LOS ANGELES,CA90001 		95-1690977 3 110,000   ACCRUAL   RESEARCH GRANT
(18) UNIVERSITY OF CALIFORNIA LOS ANGEL
UNIVERSITY OF CALIFORNIA LOS ANGEL11000 KINROSS AVENUE
11000 KINROSS AVENUE
LOS ANGELES,CA90001 		95-6006143 3 110,000   ACCRUAL   RESEARCH GRANT
(19) UNIVERSITY OF CALIFORNIA LOS ANGEL
UNIVERSITY OF CALIFORNIA LOS ANGEL11000 KINROSS AVENUE
11000 KINROSS AVENUE
LOS ANGELES,CA90001 		95-6006143 3 65,000   ACCRUAL   RESEARCH GRANT
(20) UNIVERSITY OF CALIFORNIA LOS ANGEL
UNIVERSITY OF CALIFORNIA LOS ANGEL11000 KINROSS AVENUE
11000 KINROSS AVENUE
LOS ANGELES,CA90001 		95-6006143 3 200,000   ACCRUAL   RESEARCH GRANT
(21) NANOSYN INC
NANOSYN INC3760 MAVEN AVE
3760 MAVEN AVE
MENLO PARK,CA94025 		86-0909295   422,500   FMV   THERAPY ACCELERATION
(22) UNIVERSITY OF CALIFORNIA BERKELEY
UNIVERSITY OF CALIFORNIA BERKELEY1111 FRANKLIN ST
1111 FRANKLIN ST
OAKLAND,CA94601 		94-6002123 3 55,000   ACCRUAL   RESEARCH GRANT
(23) UNIVERSITY OF CALIFORNIA BERKELEY
UNIVERSITY OF CALIFORNIA BERKELEY1111 FRANKLIN ST
1111 FRANKLIN ST
OAKLAND,CA94601 		94-6002123 3 55,000   ACCRUAL   RESEARCH GRANT
(24) CALIFORNIA INSTITUTE OF TECHNOLOGY
CALIFORNIA INSTITUTE OF TECHNOLOGY263 S CHESTER AVENUE
263 S CHESTER AVENUE
PASADENA,CA91101 		95-1643307 3 65,000   ACCRUAL   RESEARCH GRANT
(25) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(26) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(27) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(28) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(29) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(30) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(31) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(32) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(33) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(34) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 110,000   ACCRUAL   RESEARCH GRANT
(35) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 65,000   ACCRUAL   RESEARCH GRANT
(36) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 200,000   ACCRUAL   RESEARCH GRANT
(37) UNIVERSITY OF CALIFORNIA SAN FRANC
UNIVERSITY OF CALIFORNIA SAN FRANC513 PARNASSUS AVENUE
513 PARNASSUS AVENUE
SAN FRANCISCO,CA94102 		94-6036493 3 55,000   ACCRUAL   RESEARCH GRANT
(38) LELAND STANFORD JUNIOR UNIVERSITY (
LELAND STANFORD JUNIOR UNIVERSITY (279 CAMPUS DRIVE WEST
279 CAMPUS DRIVE WEST
STANFORD,CA94305 		94-1156365 3 55,000   ACCRUAL   RESEARCH GRANT
(39) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 65,000   ACCRUAL   RESEARCH GRANT
(40) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 110,000   ACCRUAL   RESEARCH GRANT
(41) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 55,000   ACCRUAL   RESEARCH GRANT
(42) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 200,000   ACCRUAL   RESEARCH GRANT
(43) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 200,000   ACCRUAL   RESEARCH GRANT
(44) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 200,000   ACCRUAL   RESEARCH GRANT
(45) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 1,250,000   ACCRUAL   RESEARCH GRANT
(46) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 65,000   ACCRUAL   RESEARCH GRANT
(47) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 110,000   ACCRUAL   RESEARCH GRANT
(48) STANFORD UNIVERSITY
STANFORD UNIVERSITY1255269 CAMPUS DRIVE
1255269 CAMPUS DRIVE
STANFORD,CA94305 		94-1156365 3 65,000   ACCRUAL   RESEARCH GRANT
(49) UNIVERSITY OF COLORADO
UNIVERSITY OF COLORADO6511 PO BOX
6511 PO BOX
AURORA,CO80045 		84-6000555 3 200,000   ACCRUAL   RESEARCH GRANT
(50) UNIVERSITY OF COLORADO
UNIVERSITY OF COLORADO6511 PO BOX
6511 PO BOX
AURORA,CO80045 		84-6000555 3 200,000   ACCRUAL   RESEARCH GRANT
(51) UNIVERSITY OF COLORADO HEALTH SCIEN
UNIVERSITY OF COLORADO HEALTH SCIEN6508 PO BOX
6508 PO BOX
AURORA,CO80045 		84-6000555 3 55,000   ACCRUAL   RESEARCH GRANT
(52) UNIVERSITY OF COLORADO
UNIVERSITY OF COLORADO6508 PO BOX
6508 PO BOX
AURORA,CO80045 		84-6000555 3 95,137   FMV   THERAPY ACCELERATION
(53) YALE UNIVERSITY
YALE UNIVERSITY208250 PO BOX
208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(54) YALE UNIVERSITY
YALE UNIVERSITY208250 PO BOX
208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 200,000   ACCRUAL   RESEARCH GRANT
(55) YALE UNIVERSITY
YALE UNIVERSITY208250 PO BOX
208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(56) YALE UNIVERSITY
YALE UNIVERSITY208250 PO BOX
208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(57) YALE UNIVERSITY
YALE UNIVERSITY208250 PO BOX
208250 PO BOX
NEW HAVEN,CT06510 		06-0646973 3 55,000   ACCRUAL   RESEARCH GRANT
(58) UNIVERSITY OF FLORIDA
UNIVERSITY OF FLORIDA113001 PO BOX
113001 PO BOX
GAINESVILLE,FL32601 		59-6002052 3 140,638   FMV   THERAPY ACCELERATION
(59) EMORY UNIVERSITY
EMORY UNIVERSITY1599 CLIFTON ROAD NE
1599 CLIFTON ROAD NE
ATLANTA,GA30303 		58-0566256 3 110,000   ACCRUAL   RESEARCH GRANT
(60) UNIVERSITY OF IOWA
UNIVERSITY OF IOWA51 NEWTON RD
51 NEWTON RD
IOWA CITY,IA52240 		42-6004813 3 55,000   ACCRUAL   RESEARCH GRANT
(61) NORTHWESTERN UNIVERSITY - CHICAGO C
NORTHWESTERN UNIVERSITY - CHICAGO C303 EAST SUPERIOR STREET
303 EAST SUPERIOR STREET
CHICAGO,IL60601 		36-2656113 3 200,000   ACCRUAL   RESEARCH GRANT
(62) NORTHWESTERN UNIVERSITY - CHICAGO C
NORTHWESTERN UNIVERSITY - CHICAGO C303 EAST SUPERIOR STREET
303 EAST SUPERIOR STREET
CHICAGO,IL60601 		36-2656113 3 1,250,000   ACCRUAL   RESEARCH GRANT
(63) NORTHWESTERN UNIVERSITY - CHICAGO C
NORTHWESTERN UNIVERSITY - CHICAGO C303 EAST SUPERIOR STREET
303 EAST SUPERIOR STREET
CHICAGO,IL60601 		36-2656113 3 65,000   ACCRUAL   RESEARCH GRANT
(64) NORTHWESTERN UNIVERSITY - CHICAGO C
NORTHWESTERN UNIVERSITY - CHICAGO C303 EAST SUPERIOR STREET
303 EAST SUPERIOR STREET
CHICAGO,IL60601 		36-2656113 3 55,000   ACCRUAL   RESEARCH GRANT
(65) THE UNIVERSITY OF CHICAGO
THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
900 EAST 57TH STREET
CHICAGO,IL60601 		3 55,000   ACCRUAL   RESEARCH GRANT
(66) THE UNIVERSITY OF CHICAGO
THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
900 EAST 57TH STREET
CHICAGO,IL60601 		3 55,000   ACCRUAL   RESEARCH GRANT
(67) THE UNIVERSITY OF CHICAGO
THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
900 EAST 57TH STREET
CHICAGO,IL60601 		3 110,000   ACCRUAL   RESEARCH GRANT
(68) THE UNIVERSITY OF CHICAGO
THE UNIVERSITY OF CHICAGO900 EAST 57TH STREET
900 EAST 57TH STREET
CHICAGO,IL60601 		3 65,000   ACCRUAL   RESEARCH GRANT
(69) UNIVERSITY OF ILLINOIS
UNIVERSITY OF ILLINOIS809 S MARSHFIELD
809 S MARSHFIELD
CHICAGO,IL60601 		37-6000511 3 110,000   ACCRUAL   RESEARCH GRANT
(70) BECKLOFF ASSOCIATES INC
BECKLOFF ASSOCIATES INC3203 SOLUTIONS CENTER
3203 SOLUTIONS CENTER
CHICAGO,IL60601 		48-0842223   265,777   FMV   THERAPY ACCELERATION
(71) INDIANA UNIVERSITY (INDIANAPOLIS)
INDIANA UNIVERSITY (INDIANAPOLIS)1044 W WALNUT STREET
1044 W WALNUT STREET
INDIANAPOLIS,IN46201 		35-6018940 3 200,000   ACCRUAL   RESEARCH GRANT
(72) BIOTECHNOLOGY INNOVATION & OPTIMIZA
BIOTECHNOLOGY INNOVATION & OPTIMIZA2097 CONSTANT AVE
2097 CONSTANT AVE
LAWRENCE,KS66044 		48-1124839 3 160,841   FMV   THERAPY ACCELERATION
(73) BETH ISRAEL DEACONESS MEDICAL CENTE
BETH ISRAEL DEACONESS MEDICAL CENTE330 BROOKLINE AVENUE
330 BROOKLINE AVENUE
BOSTON,MA02108 		04-2103881 3 200,000   ACCRUAL   RESEARCH GRANT
(74) BETH ISRAEL DEACONESS MEDICAL CENTE
BETH ISRAEL DEACONESS MEDICAL CENTE330 BROOKLINE AVENUE
330 BROOKLINE AVENUE
BOSTON,MA02108 		04-2103881 3 65,000   ACCRUAL   RESEARCH GRANT
(75) BRIGHAM & WOMENS HOSPITAL
BRIGHAM & WOMENS HOSPITAL75 FRANCIS ST
75 FRANCIS ST
BOSTON,MA02108 		04-2312909 3 1,250,000   ACCRUAL   RESEARCH GRANT
(76) BRIGHAM & WOMENS HOSPITAL
BRIGHAM & WOMENS HOSPITAL75 FRANCIS ST
75 FRANCIS ST
BOSTON,MA02108 		04-2312909 3 65,000   ACCRUAL   RESEARCH GRANT
(77) BRIGHAM & WOMENS HOSPITAL
BRIGHAM & WOMENS HOSPITAL75 FRANCIS ST
75 FRANCIS ST
BOSTON,MA02108 		04-2312909 3 110,000   ACCRUAL   RESEARCH GRANT
(78) BRIGHAM & WOMENS HOSPITAL
BRIGHAM & WOMENS HOSPITAL75 FRANCIS ST
75 FRANCIS ST
BOSTON,MA02108 		04-2312909 3 65,000   ACCRUAL   RESEARCH GRANT
(79) CHILDREN'S HOSPITAL BOSTON
CHILDREN'S HOSPITAL BOSTON300 LONGWOOD AVENUE
300 LONGWOOD AVENUE
BOSTON,MA02108 		04-2774441 3 110,000   ACCRUAL   RESEARCH GRANT
(80) DANA FARBER CANCER INSTITUTE
DANA FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(81) DANA FARBER CANCER INSTITUTE
DANA FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 100,000   ACCRUAL   RESEARCH GRANT
(82) DANA FARBER CANCER INSTITUTE
DANA FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(83) DANA FARBER CANCER INSTITUTE
DANA FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 65,000   ACCRUAL   RESEARCH GRANT
(84) DANA FARBER CANCER INSTITUTE
DANA FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 65,000   ACCRUAL   RESEARCH GRANT
(85) DANA FARBER CANCER INSTITUTE
DANA FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 110,000   ACCRUAL   RESEARCH GRANT
(86) DANA FARBER CANCER INSTITUTE
DANA FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 65,000   ACCRUAL   RESEARCH GRANT
(87) DANA-FARBER CANCER INSTITUTE
DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 65,000   ACCRUAL   RESEARCH GRANT
(88) DANA-FARBER CANCER INSTITUTE
DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(89) DANA-FARBER CANCER INSTITUTE
DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 55,000   ACCRUAL   RESEARCH GRANT
(90) DANA-FARBER CANCER INSTITUTE
DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(91) DANA-FARBER CANCER INSTITUTE
DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(92) DANA-FARBER CANCER INSTITUTE
DANA-FARBER CANCER INSTITUTE44 BINNEY STREET
44 BINNEY STREET
BOSTON,MA02108 		04-2263040 3 200,000   ACCRUAL   RESEARCH GRANT
(93) HARVARD MEDICAL SCHOOL
HARVARD MEDICAL SCHOOL1 BLACKFAN CIRCLE
1 BLACKFAN CIRCLE
BOSTON,MA02108 		53-0199180 3 1,250,000   ACCRUAL   RESEARCH GRANT
(94) HARVARD MEDICAL SCHOOL
HARVARD MEDICAL SCHOOL1 BLACKFAN CIRCLE
1 BLACKFAN CIRCLE
BOSTON,MA02108 		53-0199180 3 65,000   ACCRUAL   RESEARCH GRANT
(95) HARVARD MEDICAL SCHOOL
HARVARD MEDICAL SCHOOL1 BLACKFAN CIRCLE
1 BLACKFAN CIRCLE
BOSTON,MA02108 		53-0199180 3 55,000   ACCRUAL   RESEARCH GRANT
(96) HARVARD UNIVERSITY SCHOOL OF PUBLIC
HARVARD UNIVERSITY SCHOOL OF PUBLIC651 HUNTINGTON AVENUE
651 HUNTINGTON AVENUE
BOSTON,MA02108 		53-0199180 3 55,000   ACCRUAL   RESEARCH GRANT
(97) IMMUNE DISEASE INSTITUTE INC
IMMUNE DISEASE INSTITUTE INC3 BLACKFAN CIRCLE
3 BLACKFAN CIRCLE
BOSTON,MA02108 		04-2158520 3 65,000   ACCRUAL   RESEARCH GRANT
(98) IMMUNE DISEASE INSTITUTE INC
IMMUNE DISEASE INSTITUTE INC3 BLACKFAN CIRCLE
3 BLACKFAN CIRCLE
BOSTON,MA02108 		04-2158520 3 55,000   ACCRUAL   RESEARCH GRANT
(99) IMMUNE DISEASE INSTITUTE INC
IMMUNE DISEASE INSTITUTE INC3 BLACKFAN CIRCLE
3 BLACKFAN CIRCLE
BOSTON,MA02108 		04-2158520 3 55,000   ACCRUAL   RESEARCH GRANT
(100) MASSACHUSETTS GENERAL HOSPITAL (THE
MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 55,000   ACCRUAL   RESEARCH GRANT
(101) MASSACHUSETTS GENERAL HOSPITAL (THE
MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 65,000   ACCRUAL   RESEARCH GRANT
(102) MASSACHUSETTS GENERAL HOSPITAL (THE
MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 110,000   ACCRUAL   RESEARCH GRANT
(103) MASSACHUSETTS GENERAL HOSPITAL (THE
MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 55,000   ACCRUAL   RESEARCH GRANT
(104) MASSACHUSETTS GENERAL HOSPITAL (THE
MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 55,000   ACCRUAL   RESEARCH GRANT
(105) MASSACHUSETTS GENERAL HOSPITAL (THE
MASSACHUSETTS GENERAL HOSPITAL (THE50 STANIFORD STREET
50 STANIFORD STREET
BOSTON,MA02108 		04-1564655 3 110,000   ACCRUAL   RESEARCH GRANT
(106) ACETYLON PHARMACEUTICALS
ACETYLON PHARMACEUTICALS70 FARGO STREET
70 FARGO STREET
BOSTON,MA02108 		26-3506788   1,500,000   FMV   THERAPY ACCELERATION
(107) CHILDRENS HOSPITAL OF BOSTON
CHILDRENS HOSPITAL OF BOSTON414413 PO BOX
414413 PO BOX
BOSTON,MA02108 		04-2774441 3 25,000   FMV   THERAPY ACCELERATION
(108) MASSACHUSETTS INSTITUTE OF TECHNOLO
MASSACHUSETTS INSTITUTE OF TECHNOLO77 MASSACHUSETTS AVENUE
77 MASSACHUSETTS AVENUE
CAMBRIDGE,MA02138 		04-2103594 3 55,000   ACCRUAL   RESEARCH GRANT
(109) MASSACHUSETTS INSTITUTE OF TECHNOLO
MASSACHUSETTS INSTITUTE OF TECHNOLO77 MASSACHUSETTS AVENUE
77 MASSACHUSETTS AVENUE
CAMBRIDGE,MA02138 		04-2103594 3 55,000   ACCRUAL   RESEARCH GRANT
(110) WHITEHEAD INSTITUTE FOR BIOMEDICAL
WHITEHEAD INSTITUTE FOR BIOMEDICAL9 CAMBRIDGE CENTER
9 CAMBRIDGE CENTER
CAMBRIDGE,MA02138 		06-1043412 3 55,000   ACCRUAL   RESEARCH GRANT
(111) SHAPE
SHAPE55 CAMBRIDGE PARKWAY
55 CAMBRIDGE PARKWAY
CAMBRIDGE,MA02138 		26-3714475   1,254,000   FMV   THERAPY ACCELERATION
(112) EPIZYME INC
EPIZYME INC325 VASSAR STREET
325 VASSAR STREET
CAMBRIDGE,MA02138 		26-1349956   1,116,000   FMV   THERAPY ACCELERATION
(113) FORMA THERAPEUTICS
FORMA THERAPEUTICS790 MEMORIAL DRIVE
790 MEMORIAL DRIVE
CAMBRIDGE,MA02138 		26-0428600   600,000   FMV   THERAPY ACCELERATION
(114) BRANDEIS UNIVERSITY
BRANDEIS UNIVERSITY415 SOUTH STREET
415 SOUTH STREET
WALTHAM,MA02543 		04-2103552 3 55,000   ACCRUAL   RESEARCH GRANT
(115) AVILA
AVILA100 BEAVER STREET
100 BEAVER STREET
WALTHAM,MA02543 		20-4599701   1,521,562   FMV   THERAPY ACCELERATION
(116) UNIVERSITY OF MASSACHUSETTS MEDICAL
UNIVERSITY OF MASSACHUSETTS MEDICAL364 PLANTATION STREET
364 PLANTATION STREET
WORCESTER,MA01605 		04-3167352 3 110,000   ACCRUAL   RESEARCH GRANT
(117) UNIVERSITY OF MASSACHUSETTS MEDICAL
UNIVERSITY OF MASSACHUSETTS MEDICAL364 PLANTATION STREET
364 PLANTATION STREET
WORCESTER,MA01605 		04-3167352 3 55,000   ACCRUAL   RESEARCH GRANT
(118) UNIVERSITY OF MASSACHUSETTS MEDICAL
UNIVERSITY OF MASSACHUSETTS MEDICAL364 PLANTATION STREET
364 PLANTATION STREET
WORCESTER,MA01605 		04-3167352 3 110,000   ACCRUAL   RESEARCH GRANT
(119) UNIVERSITY OF MASSACHUSETTS MEDICAL
UNIVERSITY OF MASSACHUSETTS MEDICAL364 PLANTATION STREET
364 PLANTATION STREET
WORCESTER,MA01605 		04-3167352 3 200,000   ACCRUAL   RESEARCH GRANT
(120) JOHNS HOPKINS UNIVERSITY
JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(121) JOHNS HOPKINS UNIVERSITY
JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(122) JOHNS HOPKINS UNIVERSITY
JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(123) JOHNS HOPKINS UNIVERSITY
JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 65,000   ACCRUAL   RESEARCH GRANT
(124) JOHNS HOPKINS UNIVERSITY
JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(125) JOHNS HOPKINS UNIVERSITY
JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(126) JOHNS HOPKINS UNIVERSITY
JOHNS HOPKINS UNIVERSITY1101 EAST 33RD STREET
1101 EAST 33RD STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(127) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 55,000   ACCRUAL   RESEARCH GRANT
(128) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(129) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(130) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 110,000   ACCRUAL   RESEARCH GRANT
(131) JOHNS HOPKINS UNIVERSITY SCHOOL OF
JOHNS HOPKINS UNIVERSITY SCHOOL OF725 NORTH WOLFE STREET
725 NORTH WOLFE STREET
BALTIMORE,MD21201 		52-0595110 3 200,000   ACCRUAL   RESEARCH GRANT
(132) UNIVERSITY OF MARYLAND BALTIMORE
UNIVERSITY OF MARYLAND BALTIMORE655 WEST BALTIMORE STREET
655 WEST BALTIMORE STREET
BALTIMORE,MD21201 		52-6002033 3 200,000   ACCRUAL   RESEARCH GRANT
(133) UNIVERSITY OF MARYLAND BALTIMORE
UNIVERSITY OF MARYLAND BALTIMORE655 WEST BALTIMORE STREET
655 WEST BALTIMORE STREET
BALTIMORE,MD21201 		52-6002033 3 200,000   ACCRUAL   RESEARCH GRANT
(134) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(135) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(136) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 65,000   ACCRUAL   RESEARCH GRANT
(137) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(138) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(139) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(140) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(141) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 110,000   ACCRUAL   RESEARCH GRANT
(142) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 200,000   ACCRUAL   RESEARCH GRANT
(143) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN1500 E MEDICAL CENTER DRIVE
1500 E MEDICAL CENTER DRIVE
ANN ARBOR,MI48109 		38-6006309 3 55,000   ACCRUAL   RESEARCH GRANT
(144) UNIVERSITY OF MINNESOTA
UNIVERSITY OF MINNESOTA450 MCNAMARA ALUMNI CENTER
450 MCNAMARA ALUMNI CENTER
MINNEAPOLIS,MN55401 		41-6007513 3 110,000   ACCRUAL   RESEARCH GRANT
(145) UNIVERSITY OF MINNESOTA - TWIN CITI
UNIVERSITY OF MINNESOTA - TWIN CITI321 CHURCH STREET SE
321 CHURCH STREET SE
MINNEAPOLIS,MN55401 		41-6007513 3 110,000   ACCRUAL   RESEARCH GRANT
(146) UNIVERSITY OF MINNESOTA - TWIN CITI
UNIVERSITY OF MINNESOTA - TWIN CITI321 CHURCH STREET SE
321 CHURCH STREET SE
MINNEAPOLIS,MN55401 		41-6007513 3 200,000   ACCRUAL   RESEARCH GRANT
(147) UNIVERSITY OF MINNESOTA - TWIN CITI
UNIVERSITY OF MINNESOTA - TWIN CITI321 CHURCH STREET SE
321 CHURCH STREET SE
MINNEAPOLIS,MN55401 		41-6007513 3 65,000   ACCRUAL   RESEARCH GRANT
(148) UNIVERSITY OF MINNESOTA TWIN CITIE
UNIVERSITY OF MINNESOTA TWIN CITIE321 CHURCH STREET SE
321 CHURCH STREET SE
MINNEAPOLIS,MN55401 		41-6007513 3 110,000   ACCRUAL   RESEARCH GRANT
(149) MAYO CLINIC & FOUNDATION
MAYO CLINIC & FOUNDATION200 FIRST STREET
200 FIRST STREET
ROCHESTER,MN55901 		41-1506440 3 100,000   ACCRUAL   RESEARCH GRANT
(150) MAYO CLINIC & FOUNDATION
MAYO CLINIC & FOUNDATION200 FIRST STREET
200 FIRST STREET
ROCHESTER,MN55901 		41-1506440 3 110,000   ACCRUAL   RESEARCH GRANT
(151) MAYO CLINIC & FOUNDATION
MAYO CLINIC & FOUNDATION200 FIRST STREET
200 FIRST STREET
ROCHESTER,MN55901 		41-1506440 3 200,000   ACCRUAL   RESEARCH GRANT
(152) MAYO CLINIC & FOUNDATION
MAYO CLINIC & FOUNDATION200 FIRST STREET
200 FIRST STREET
ROCHESTER,MN55901 		41-1506440 3 200,000   ACCRUAL   RESEARCH GRANT
(153) MAYO CLINIC & FOUNDATION
MAYO CLINIC & FOUNDATION200 FIRST STREET
200 FIRST STREET
ROCHESTER,MN55901 		41-1506440 3 110,000   ACCRUAL   RESEARCH GRANT
(154) STOWERS INSTITUTE FOR MEDICAL RESEA
STOWERS INSTITUTE FOR MEDICAL RESEA1000 EAST 50TH STREET
1000 EAST 50TH STREET
KANSAS CITY,MO64110 		43-6384454 3 55,000   ACCRUAL   RESEARCH GRANT
(155) WASHINGTON UNIVERSITY IN ST LOUIS
WASHINGTON UNIVERSITY IN ST LOUIS660 S EUCLID AVE
660 S EUCLID AVE
ST LOUIS,MO63110 		43-0653611 3 65,000   ACCRUAL   RESEARCH GRANT
(156) WASHINGTON UNIVERSITY IN ST LOUIS
WASHINGTON UNIVERSITY IN ST LOUIS660 S EUCLID AVE
660 S EUCLID AVE
ST LOUIS,MO63110 		43-0653611 3 200,000   ACCRUAL   RESEARCH GRANT
(157) WASHINGTON UNIVERSITY IN ST LOUIS
WASHINGTON UNIVERSITY IN ST LOUIS660 S EUCLID AVE
660 S EUCLID AVE
ST LOUIS,MO63110 		43-0653611 3 200,000   ACCRUAL   RESEARCH GRANT
(158) WASHINGTON UNIVERSITY IN ST LOUIS
WASHINGTON UNIVERSITY IN ST LOUIS660 S EUCLID AVE
660 S EUCLID AVE
ST LOUIS,MO63110 		43-0653611 3 110,000   ACCRUAL   RESEARCH GRANT
(159) UNIVERSITY OF NORTH CAROLINA AT CHA
UNIVERSITY OF NORTH CAROLINA AT CHA101 MANNING DRIVE
101 MANNING DRIVE
CHAPEL HILL,NC27514 		56-6001393 3 65,000   ACCRUAL   RESEARCH GRANT
(160) UNIVERSITY OF NORTH CAROLINA AT CHA
UNIVERSITY OF NORTH CAROLINA AT CHA101 MANNING DRIVE
101 MANNING DRIVE
CHAPEL HILL,NC27514 		56-6001393 3 200,000   ACCRUAL   RESEARCH GRANT
(161) UNIVERSITY OF NORTH CAROLINA AT CHA
UNIVERSITY OF NORTH CAROLINA AT CHA101 MANNING DRIVE
101 MANNING DRIVE
CHAPEL HILL,NC27514 		56-6001393 3 110,000   ACCRUAL   RESEARCH GRANT
(162) DUKE UNIVERSITY
DUKE UNIVERSITY2200 WEST MAIN STREET
2200 WEST MAIN STREET
DURHAM,NC27701 		56-0532129 3 110,000   ACCRUAL   RESEARCH GRANT
(163) DUKE UNIVERSITY
DUKE UNIVERSITY2200 WEST MAIN STREET
2200 WEST MAIN STREET
DURHAM,NC27701 		56-0532129 3 65,000   ACCRUAL   RESEARCH GRANT
(164) DUKE UNIVERSITY
DUKE UNIVERSITY2200 WEST MAIN STREET
2200 WEST MAIN STREET
DURHAM,NC27701 		56-0532129 3 55,000   ACCRUAL   RESEARCH GRANT
(165) DUKE UNIVERSITY
DUKE UNIVERSITY2200 WEST MAIN STREET
2200 WEST MAIN STREET
DURHAM,NC27701 		56-0532129 3 110,000   ACCRUAL   RESEARCH GRANT
(166) DUKE UNIVERSITY
DUKE UNIVERSITY2200 WEST MAIN STREET
2200 WEST MAIN STREET
DURHAM,NC27701 		56-0532129 3 110,000   ACCRUAL   RESEARCH GRANT
(167) UMDNJ--ROBERT WOOD JOHNSON MEDICAL
UMDNJ--ROBERT WOOD JOHNSON MEDICAL335 GEORGE STREET
335 GEORGE STREET
NEW BRUNSWICK,NJ08901 		22-1776306 3 200,000   ACCRUAL   RESEARCH GRANT
(168) CELATOR PHARMACEUTICALS
CELATOR PHARMACEUTICALS303B COLLEGE ROAD EAST
303B COLLEGE ROAD EAST
PRINCETON,NJ08540 		20-2680869   980,000   FMV   THERAPY ACCELERATION
(169) ALBERT EINSTEIN COLLEGE OF MEDICINE
ALBERT EINSTEIN COLLEGE OF MEDICINE1300 MORRIS PARK AVE
1300 MORRIS PARK AVE
BRONX,NY10461 		13-1624225 3 200,000   ACCRUAL   RESEARCH GRANT
(170) ALBERT EINSTEIN COLLEGE OF MEDICINE
ALBERT EINSTEIN COLLEGE OF MEDICINE1300 MORRIS PARK AVE
1300 MORRIS PARK AVE
BRONX,NY10461 		13-1624225 3 200,000   ACCRUAL   RESEARCH GRANT
(171) HEALTH RESEARCH INCORPORATED ROSWE
HEALTH RESEARCH INCORPORATED ROSWE1 ELM CARLTON STREETS
1 ELM CARLTON STREETS
BUFFALO,NY14201 		04-2158520 3 100,000   ACCRUAL   RESEARCH GRANT
(172) HEALTH RESEARCH INCORPORATED ROSWE
HEALTH RESEARCH INCORPORATED ROSWE1 ELM CARLTON STREETS
1 ELM CARLTON STREETS
BUFFALO,NY14201 		04-2158520 3 110,000   ACCRUAL   RESEARCH GRANT
(173) BIOTHERYX
BIOTHERYX20 CABIN RIDGE ROAD
20 CABIN RIDGE ROAD
CHAPPAQUA,NY10514 		26-0201342   4,500,000   FMV   THERAPY ACCELERATION
(174) COLD SPRING HARBOR LABORATORY
COLD SPRING HARBOR LABORATORY1 BUNGTOWN ROAD
1 BUNGTOWN ROAD
COLD SPRING HARBOR,NY11724 		11-1631792 3 1,250,000   ACCRUAL   RESEARCH GRANT
(175) COLUMBIA UNIVERSITY
COLUMBIA UNIVERSITY1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 1,250,000   ACCRUAL   RESEARCH GRANT
(176) COLUMBIA UNIVERSITY
COLUMBIA UNIVERSITY1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(177) COLUMBIA UNIVERSITY
COLUMBIA UNIVERSITY1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 110,000   ACCRUAL   RESEARCH GRANT
(178) COLUMBIA UNIVERSITY
COLUMBIA UNIVERSITY1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 110,000   ACCRUAL   RESEARCH GRANT
(179) COLUMBIA UNIVERSITY
COLUMBIA UNIVERSITY1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 110,000   ACCRUAL   RESEARCH GRANT
(180) COLUMBIA UNIVERSITY MEDICAL CENTER
COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(181) COLUMBIA UNIVERSITY MEDICAL CENTER
COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 55,000   ACCRUAL   RESEARCH GRANT
(182) COLUMBIA UNIVERSITY MEDICAL CENTER
COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 200,000   ACCRUAL   RESEARCH GRANT
(183) COLUMBIA UNIVERSITY MEDICAL CENTER
COLUMBIA UNIVERSITY MEDICAL CENTER1150 ST NICHOLAS AVENUE
1150 ST NICHOLAS AVENUE
NEW YORK,NY10001 		13-5598093 3 55,000   ACCRUAL   RESEARCH GRANT
(184) CORNELL UNIVERSITY MEDICAL COLLEGE
CORNELL UNIVERSITY MEDICAL COLLEGE1300 YORK AVE
1300 YORK AVE
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(185) CORNELL UNIVERSITY MEDICAL COLLEGE
CORNELL UNIVERSITY MEDICAL COLLEGE1300 YORK AVE
1300 YORK AVE
NEW YORK,NY10001 		13-3376695 3 65,000   ACCRUAL   RESEARCH GRANT
(186) CORNELL UNIVERSITY MEDICAL COLLEGE
CORNELL UNIVERSITY MEDICAL COLLEGE1300 YORK AVE
1300 YORK AVE
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(187) CORNELL UNIVERSITY MEDICAL COLLEGE
CORNELL UNIVERSITY MEDICAL COLLEGE1300 YORK AVE
1300 YORK AVE
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(188) JOAN & SANFORD I WEILL MEDICAL COL
JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 65,000   ACCRUAL   RESEARCH GRANT
(189) JOAN & SANFORD I WEILL MEDICAL COL
JOAN & SANFORD I WEILL MEDICAL COL435 EAST 70TH STREET
435 EAST 70TH STREET
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(190) MEMORIAL SLOAN KETTERING CANCER CEN
MEMORIAL SLOAN KETTERING CANCER CEN633 THIRD AVENUE
633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 55,000   ACCRUAL   RESEARCH GRANT
(191) MEMORIAL SLOAN-KETTERING CANCER CEN
MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 200,000   ACCRUAL   RESEARCH GRANT
(192) MEMORIAL SLOAN-KETTERING CANCER CEN
MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 55,000   ACCRUAL   RESEARCH GRANT
(193) MEMORIAL SLOAN-KETTERING CANCER CEN
MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 200,000   ACCRUAL   RESEARCH GRANT
(194) MEMORIAL SLOAN-KETTERING CANCER CEN
MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 65,000   ACCRUAL   RESEARCH GRANT
(195) MEMORIAL SLOAN-KETTERING CANCER CEN
MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 200,000   ACCRUAL   RESEARCH GRANT
(196) MEMORIAL SLOAN-KETTERING CANCER CEN
MEMORIAL SLOAN-KETTERING CANCER CEN633 THIRD AVENUE
633 THIRD AVENUE
NEW YORK,NY10001 		91-2154267 3 55,000   ACCRUAL   RESEARCH GRANT
(197) NEW YORK UNIVERSITY SCHOOL OF MEDIC
NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 200,000   ACCRUAL   RESEARCH GRANT
(198) NEW YORK UNIVERSITY SCHOOL OF MEDIC
NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 65,000   ACCRUAL   RESEARCH GRANT
(199) NEW YORK UNIVERSITY SCHOOL OF MEDIC
NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 65,000   ACCRUAL   RESEARCH GRANT
(200) NEW YORK UNIVERSITY SCHOOL OF MEDIC
NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 200,000   ACCRUAL   RESEARCH GRANT
(201) NEW YORK UNIVERSITY SCHOOL OF MEDIC
NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 200,000   ACCRUAL   RESEARCH GRANT
(202) NEW YORK UNIVERSITY SCHOOL OF MEDIC
NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 65,000   ACCRUAL   RESEARCH GRANT
(203) NEW YORK UNIVERSITY SCHOOL OF MEDIC
NEW YORK UNIVERSITY SCHOOL OF MEDIC550 FIRST AVENUE
550 FIRST AVENUE
NEW YORK,NY10001 		13-6171197 3 110,000   ACCRUAL   RESEARCH GRANT
(204) ROCKEFELLER UNIVERSITY
ROCKEFELLER UNIVERSITY1230 YORK AVENUE
1230 YORK AVENUE
NEW YORK,NY10001 		13-1624158 3 110,000   ACCRUAL   RESEARCH GRANT
(205) WEILL MEDICAL COLLEGE OF CORNELL UN
WEILL MEDICAL COLLEGE OF CORNELL UN575 LEXINGTON AVENUE
575 LEXINGTON AVENUE
NEW YORK,NY10001 		13-3376695 3 200,000   ACCRUAL   RESEARCH GRANT
(206) ROCKEFELLER UNIVERSITY
ROCKEFELLER UNIVERSITY1230 YORK AVENUE
1230 YORK AVENUE
NEW YORK,NY10001 		13-1624158 3 55,000   ACCRUAL   RESEARCH GRANT
(207) UNIVERSITY OF ROCHESTER
UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 200,000   ACCRUAL   RESEARCH GRANT
(208) UNIVERSITY OF ROCHESTER
UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 110,000   ACCRUAL   RESEARCH GRANT
(209) UNIVERSITY OF ROCHESTER
UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 200,000   ACCRUAL   RESEARCH GRANT
(210) UNIVERSITY OF ROCHESTER
UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 200,000   ACCRUAL   RESEARCH GRANT
(211) UNIVERSITY OF ROCHESTER
UNIVERSITY OF ROCHESTER601 ELMWOOD AVENUE
601 ELMWOOD AVENUE
ROCHESTER,NY14603 		16-0473209 3 110,000   ACCRUAL   RESEARCH GRANT
(212) CHILDRENS HOSPITAL MEDICAL CENTER-C
CHILDRENS HOSPITAL MEDICAL CENTER-C7013 3333 BURNET AVENUE
7013 3333 BURNET AVENUE
CINCINNATI,OH45202 		31-0833936 3 110,000   ACCRUAL   RESEARCH GRANT
(213) CHILDRENS HOSPITAL MEDICAL CENTER-C
CHILDRENS HOSPITAL MEDICAL CENTER-C7013 3333 BURNET AVENUE
7013 3333 BURNET AVENUE
CINCINNATI,OH45202 		31-0833936 3 110,000   ACCRUAL   RESEARCH GRANT
(214) UNIVERSITY OF CINCINNATI
UNIVERSITY OF CINCINNATI231 ALBERT SABIN WAY
231 ALBERT SABIN WAY
CINCINNATI,OH45202 		31-6000989 3 110,000   ACCRUAL   RESEARCH GRANT
(215) CLEVELAND CLINIC
CLEVELAND CLINIC931568 PO BOX
931568 PO BOX
CLEVELAND,OH44149 		34-0714585 3 590,000   FMV   THERAPY ACCELERATION
(216) OHIO STATE UNIVERSITY
OHIO STATE UNIVERSITY1960 KENNY ROAD
1960 KENNY ROAD
COLUMBUS,OH43085 		31-6401599 3 1,250,000   ACCRUAL   RESEARCH GRANT
(217) OHIO STATE UNIVERSITY
OHIO STATE UNIVERSITY1960 KENNY ROAD
1960 KENNY ROAD
COLUMBUS,OH43085 		31-6401599 3 110,000   ACCRUAL   RESEARCH GRANT
(218) OHIO STATE UNIVERSITY
OHIO STATE UNIVERSITY1960 KENNY ROAD
1960 KENNY ROAD
COLUMBUS,OH43085 		31-6401599 3 65,000   ACCRUAL   RESEARCH GRANT
(219) OHIO STATE UNIVERSITY
OHIO STATE UNIVERSITY1960 KENNY ROAD
1960 KENNY ROAD
COLUMBUS,OH43085 		31-6401599 3 200,000   ACCRUAL   RESEARCH GRANT
(220) OREGON HEALTH & SCIENCE UNIVERSITY
OREGON HEALTH & SCIENCE UNIVERSITY3181 SW SAM JACKSON PARK RD
3181 SW SAM JACKSON PARK RD
PORTLAND,OR97239 		23-7083114 3 110,000   ACCRUAL   RESEARCH GRANT
(221) OREGON HEALTH & SCIENCE UNIVERSITY
OREGON HEALTH & SCIENCE UNIVERSITY3181 SW SAM JACKSON PARK RD
3181 SW SAM JACKSON PARK RD
PORTLAND,OR97239 		23-7083114 3 1,250,000   ACCRUAL   RESEARCH GRANT
(222) OREGON HEALTH & SCIENCE UNIVERSITY
OREGON HEALTH & SCIENCE UNIVERSITY3181 SW SAM JACKSON PARK RD
3181 SW SAM JACKSON PARK RD
PORTLAND,OR97239 		23-7083114 3 110,000   ACCRUAL   RESEARCH GRANT
(223) ASCENTA THERAPEUTICS
ASCENTA THERAPEUTICS101 LINDENWOOD DRIVE
101 LINDENWOOD DRIVE
MALVERN,PA19355 		56-2394460   1,150,007   FMV   THERAPY ACCELERATION
(224) ONCONOVA
ONCONOVA375 PHEASANT RUN
375 PHEASANT RUN
NEWTOWN,PA18940 		22-3627252   1,900,000   FMV   THERAPY ACCELERATION
(225) CHILDRENS HOSPITAL OF PHILADELPHIA
CHILDRENS HOSPITAL OF PHILADELPHIA3615 CIVIC CENTER BOULEVARD
3615 CIVIC CENTER BOULEVARD
PHILADELPHIA,PA19102 		23-1352166 3 110,000   ACCRUAL   RESEARCH GRANT
(226) DREXEL UNIVERSITY
DREXEL UNIVERSITY497 245 N 15TH STREET
497 245 N 15TH STREET
PHILADELPHIA,PA19102 		23-1352630 3 110,000   ACCRUAL   RESEARCH GRANT
(227) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(228) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(229) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(230) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(231) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(232) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 200,000   ACCRUAL   RESEARCH GRANT
(233) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 55,000   ACCRUAL   RESEARCH GRANT
(234) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 65,000   ACCRUAL   RESEARCH GRANT
(235) UNIVERSITY OF PENNSYLVANIA
UNIVERSITY OF PENNSYLVANIA3451 WALNUT STREET
3451 WALNUT STREET
PHILADELPHIA,PA19102 		23-1352685 3 55,000   ACCRUAL   RESEARCH GRANT
(236) UNIVERSITY OF PITTSBURGH
UNIVERSITY OF PITTSBURGH5117 CENTER AVE
5117 CENTER AVE
PITTSBURGH,PA15213 		25-0965591 3 110,000   ACCRUAL   RESEARCH GRANT
(237) UNIVERSITY OF PITTSBURGH
UNIVERSITY OF PITTSBURGH5117 CENTER AVE
5117 CENTER AVE
PITTSBURGH,PA15213 		25-0965591 3 200,000   ACCRUAL   RESEARCH GRANT
(238) UNIVERSITY OF PITTSBURGH
UNIVERSITY OF PITTSBURGH5117 CENTER AVE
5117 CENTER AVE
PITTSBURGH,PA15213 		25-0965591 3 200,000   ACCRUAL   RESEARCH GRANT
(239) UNIVERSITY OF MICHIGAN
UNIVERSITY OF MICHIGAN223131 PO BOX
223131 PO BOX
PITTSBURGH,PA15213 		38-6006309 3 41,800   FMV   THERAPY ACCELERATION
(240) VANDERBILT UNIVERSITY MEDICAL CENTE
VANDERBILT UNIVERSITY MEDICAL CENTE2220 PIERCE AVE
2220 PIERCE AVE
NASHVILLE,TN37201 		62-0476822 3 200,000   ACCRUAL   RESEARCH GRANT
(241) MEMGEN
MEMGEN7557 RAMBLER ROAD
7557 RAMBLER ROAD
DALLAS,TX75201 		35-2232976   810,795   FMV   THERAPY ACCELERATION
(242) BAYLOR COLLEGE OF MEDICINE
BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 110,000   ACCRUAL   RESEARCH GRANT
(243) BAYLOR COLLEGE OF MEDICINE
BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 200,000   ACCRUAL   RESEARCH GRANT
(244) BAYLOR COLLEGE OF MEDICINE
BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 65,000   ACCRUAL   RESEARCH GRANT
(245) BAYLOR COLLEGE OF MEDICINE
BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 1,250,000   ACCRUAL   RESEARCH GRANT
(246) BAYLOR COLLEGE OF MEDICINE
BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 200,000   ACCRUAL   RESEARCH GRANT
(247) BAYLOR COLLEGE OF MEDICINE
BAYLOR COLLEGE OF MEDICINE1 BAYLOR PLAZA
1 BAYLOR PLAZA
HOUSTON,TX77002 		74-1613878 3 200,000   ACCRUAL   RESEARCH GRANT
(248) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 55,000   ACCRUAL   RESEARCH GRANT
(249) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(250) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(251) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(252) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(253) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 1,250,000   ACCRUAL   RESEARCH GRANT
(254) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(255) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(256) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(257) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(258) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(259) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(260) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(261) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 110,000   ACCRUAL   RESEARCH GRANT
(262) UNIVERSITY OF TEXAS
UNIVERSITY OF TEXAS1515 HOLCOMBE BLVD UNIT 202
1515 HOLCOMBE BLVD UNIT 202
HOUSTON,TX77002 		76-0300816 3 200,000   ACCRUAL   RESEARCH GRANT
(263) UNIVERSITY OF TEXAS SAN ANTONIO
UNIVERSITY OF TEXAS SAN ANTONIO7703 FLOYD CURL DRIVE
7703 FLOYD CURL DRIVE
SAN ANTONIO,TX78229 		74-1717115 3 200,000   ACCRUAL   RESEARCH GRANT
(264) UNIVERSITY OF UTAH
UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(265) UNIVERSITY OF UTAH
UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 55,000   ACCRUAL   RESEARCH GRANT
(266) UNIVERSITY OF UTAH
UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(267) UNIVERSITY OF UTAH
UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(268) UNIVERSITY OF UTAH
UNIVERSITY OF UTAH2000 CIRCLE OF HOPE
2000 CIRCLE OF HOPE
SALT LAKE CITY,UT84112 		87-6000525 3 200,000   ACCRUAL   RESEARCH GRANT
(269) VIRGINIA COMMONWEALTH UNIVERSITY
VIRGINIA COMMONWEALTH UNIVERSITY401 COLLEGE STREET
401 COLLEGE STREET
RICHMOND,VA23298 		54-6001758 3 200,000   ACCRUAL   RESEARCH GRANT
(270) FRED HUTCHINSON CANCER RESEARCH CEN
FRED HUTCHINSON CANCER RESEARCH CEN1100 FAIRVIEW AVENUE NORTH
1100 FAIRVIEW AVENUE NORTH
SEATTLE,WA98109 		23-7156071 3 1,250,000   ACCRUAL   RESEARCH GRANT
(271) FRED HUTCHINSON CANCER RESEARCH CEN
FRED HUTCHINSON CANCER RESEARCH CEN1100 FAIRVIEW AVENUE NORTH
1100 FAIRVIEW AVENUE NORTH
SEATTLE,WA98109 		23-7156071 3 65,000   ACCRUAL   RESEARCH GRANT
(272) FRED HUTCHINSON CANCER RESEARCH CEN
FRED HUTCHINSON CANCER RESEARCH CEN1100 FAIRVIEW AVENUE NORTH
1100 FAIRVIEW AVENUE NORTH
SEATTLE,WA98109 		23-7156071 3 55,000   ACCRUAL   RESEARCH GRANT
(273) FRED HUTCHINSON CANCER RESEARCH CEN
FRED HUTCHINSON CANCER RESEARCH CEN1100 FAIRVIEW AVENUE NORTH
1100 FAIRVIEW AVENUE NORTH
SEATTLE,WA98109 		23-7156071 3 65,000   ACCRUAL   RESEARCH GRANT
(274) UNIVERSITY OF WASHINGTON
UNIVERSITY OF WASHINGTON1100 NE 45TH STREET
1100 NE 45TH STREET
SEATTLE,WA98105 		91-6001537 3 110,000   ACCRUAL   RESEARCH GRANT
(275) UNIVERSITY OF WASHINGTON
UNIVERSITY OF WASHINGTON1100 NE 45TH STREET
1100 NE 45TH STREET
SEATTLE,WA98105 		91-6001537 3 55,000   ACCRUAL   RESEARCH GRANT
(276) UNIVERSITY OF WASHINGTON
UNIVERSITY OF WASHINGTON1100 NE 45TH STREET
1100 NE 45TH STREET
SEATTLE,WA98105 		91-6001537 3 65,000   ACCRUAL   RESEARCH GRANT
(277) BLOOD RESEARCH INSTITUTE BLOOD CE
BLOOD RESEARCH INSTITUTE BLOOD CE8727 W WATERTOWN PLANK ROAD
8727 W WATERTOWN PLANK ROAD
MILWAUKEE,WI53226 		39-0807235 3 110,000   ACCRUAL   RESEARCH GRANT
(278) MEDICAL COLLEGE OF WISCONSIN
MEDICAL COLLEGE OF WISCONSIN8701 WATERTOWN PLANK ROAD
8701 WATERTOWN PLANK ROAD
MILWAUKEE,WI53226 		3 110,000   ACCRUAL   RESEARCH GRANT
2
Enter total number of section 501(c)(3) and government organizations ......................... Bullet Image
266
3
Enter total number of other organizations ................................ . Bullet Image
12
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2010

Schedule I (Form 990) 2010
Page 2
Part III
Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Use Schedule I-1 (Form 990) if additional space is needed.
(a)Type of grant or assistance (b)Number of
recipients		 (c)Amount of
cash grant		 (d)Amount of
non-cash assistance		 (e)Method of valuation (book,
FMV, appraisal, other)		 (f)Description of non-cash assistance
(1) PATIENT AID 37210 5,579,396      
(2) CO-PAY ASSISTANCE-CML 1126 3,870,000      
(3) CO-PAY ASSISTANCE-CLL 1468 5,040,000      
(4) CO-PAY ASSISTANCE-LYMPHOM 5611 14,367,178      
(5) CO-PAY ASSISTANCE-MDS 1041 2,789,737      
(6) CO-PAY ASSISTANCE-MYELOMA 3884 11,880,000      



Part IV
Supplemental Information. Complete this part to provide the information required in Part I, line 2, and any other additional information.
Identifier Return Reference Explanation
PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS INSIDE THE UNITED STATES SCHEDULE I, PAGE 1, PART I, LINE 2 FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD.WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS,EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT.
Schedule I (Form 990) 2010


Additional Data


Software ID:  
Software Version:  


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" to Form 990,
Part IV, question 23.
SchJMediumBullet Attach to Form 990. SchJMediumBullet See separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement orprovision of all the expenses described above? If "No," complete Part III to explain....
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
officers, directors, trustees, and the CEO/Executive Director, regarding the items checked in line 1a? ....
2
 
 
3
Indicate which, if any, of the following the organization uses to establish the compensation of the
organization's CEO/Executive Director. Check all that apply.
4
During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? ...............
4a
 
No
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? ........
4b
 
No
c
Participate in, or receive payment from, an equity-based compensation arrangement? ........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.
5
For persons listed in form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ...........................
5a
 
No
b
Any related organization? .........................
5b
 
No
If "Yes," to line 5a or 5b, describe in Part III.
6
For persons listed in form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ...........................
6a
 
No
b
Any related organization? .........................
6b
 
No
If "Yes," to line 6a or 6b, describe in Part III.
7
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
Yes
 
8
Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regs. section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................
8
 
No
9
If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Privacy Act and Paperwork Reduction Act Notice, see the Intructions for Form 990
Cat. No. 50053T
Schedule J (Form 990) 2010

Schedule J (Form 990) 2010
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use Schedule J-1 if additional space needed.
For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.

Note. The sum of columns (B)(i)-(iii) must equal the applicable column (D) or column (E) amounts on Form 990, Part VII, line 1a.
(A) Name (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation
reported in prior
Form 990 or
Form 990-EZ
(i) Base compensation (ii) Bonus & incentive compensation (iii) Other reportable compensation
(1) JOHN WALTER (i)
(ii)		 475,000
  		38,000
  		6,525
  		30,870
  		21,623
  		572,018
  		 
 
(2) JAMES T NANGLE (i)
(ii)		 212,292
  		10,549
  		9,975
  		22,284
  		21,623
  		276,723
  		 
 
(3) LOUIS DEGENNARO (i)
(ii)		 315,217
  		22,050
  		8,789
  		24,500
  		14,609
  		385,165
  		 
 
(4) NANCY KLEIN (i)
(ii)		 315,051
  		12,600
  		9,919
  		24,500
  		21,623
  		383,693
  		 
 
(5) DAVID TIMKO (i)
(ii)		 230,830
  		4,568
  		12,066
  		23,451
  		14,609
  		285,524
  		 
 
(6) MICHAEL OSSO (i)
(ii)		 210,769
  		9,215
  		10,537
  		14,911
  		14,603
  		260,035
  		 
 
(7) GEORGE OMIROS (i)
(ii)		 205,904
  		4,093
  		9,959
  		21,000
  		14,609
  		255,565
  		 
 









Schedule J (Form 990) 2010

Schedule J (Form 990) 2010
Page 3
Part III
Supplemental Information
Complete this part to provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 4c, 5a, 5b, 6a, 6b, 7, and 8. Also complete this part for any additional information.
Identifier Return Reference Explanation
NON-FIXED PAYMENTS PROVIDED SCHEDULE J, PAGE 1, PART I, LINE 7 BONUSES WERE PAID BASED ON THE ACHIEVEMENT OF GROSS REVENUE EXCEEDING BUDGETED GROSS REVENUE,EMPLOYEE INDIVIDUAL PERFORMANCE AND OTHER METRICS. BONUSES WERE CAPPED ACCORDING TO LLS'S POLICY.
Schedule J (Form 990) 2010

Additional Data


Software ID:  
Software Version:  
Schedule L
(Form 990 or 990-EZ)
Department of the Treasury
Internal Revenue Service
Transactions with Interested Persons
MediumBullet Complete if the organization answered
"Yes" on Form 990, Part IV, lines 25a, 25b, 26, 27, 28a, 28b, or 28c,
or Form 990-EZ, Part V lines 38a or 40b.
MediumBullet Attach to Form 990 or Form 990-EZ. MediumBulletSee separate instructions.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I
Excess Benefit Transactions (section 501(c)(3) and section 501 (c)(4) organizations only).
Complete if the organization answered "Yes" on Form 990, Part IV, line 25a or 25b, or Form 990-EZ, Part V, line 40b.
1(a) Name of disqualified person (b) Description of transaction (c) Corrected?
Yes No





2
Enter the amount of tax imposed on the organization managers or disqualified persons during the year under section 4958. ......................... Bullet Image$
 
3
Enter the amount of tax, if any, on line 2, above, reimbursed by the organization ....... Bullet Image$
 

Part II
Loans to and/or From Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 26, or Form 990-EZ, Part V, line 38a.
(a) Name of interested person and purpose (b) Loan to or from the organization? (c)Original principal amount (d)Balance due (e) In default? (f) Approved by board or committee? (g)Written agreement?
To From Yes No Yes No Yes No
Total ...............Small Bullet $  
Part III
Grants or Assistance Benefitting Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 27.
(a) Name of interested person (b)Relationship between interested person and the organization (c)Amount of grant or type of assistance
For Privacy Act and Paperwork Reduction Act Notice, see the
Instructions for Form 990 or 990-EZ.
Cat. No. 50056A
Schedule L (Form 990 or 990-EZ) 2010
Schedule L (Form 990 or 990-EZ) 2010
Page 2
Part IV
Business Transactions Involving Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 28a, 28b, or 28c.
(a) Name of interested person (b) Relationship between interested person and the organization (c) Amount of transaction (d) Description of transaction (e) Sharing of organization's revenues?
Yes No
(1) JAMES DAVIS BOD MEMBER 307,026 EQUITY IN AEGERA   No
Part V
Supplemental Information
Complete this part to provide additional information for responses to questions on Schedule L (see instructions).
Identifier Return Reference Explanation
ADDITIONAL INFORMATION SCHEDULE L PART V PART IV LINE 1 JAMES DAVIS IS AN EXECUTIVE OFFICER WITH HUMAN GENOME SCIENCES WHICH HAS AN EQUITY STAKE IN AEGERA THERAPEUTICS A RECIPIENT OF A THERAPY ACCELERATION PROJECT CONTRACT
Schedule L (Form 990 or 990-EZ) 2010

Additional Data


Software ID:  
Software Version:  




SCHEDULE M
(Form 990)

Department of the Treasury
Internal Revenue Service
NonCash Contributions
Right pointing arrow large imageComplete if the organization answered "Yes" on Form 990, Part IV, lines 29 or 30.
Right pointing arrow large image Attach to Form 990.
OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I
Types of Property
(a)
Check if applicable 		(b)
Number of Contributions or items contributed 		(c)
Contribution amounts reported on
Form 990, Part VIII, line 1g 		(d)
Method of determining
contribution amounts
1 Art—Works of art ....        
2 Art—Historical treasures .        
3 Art—Fractional interests ..        
4 Books and publications ..      
5 Clothing and household
goods ....... 		     
6 Cars and other vehicles ..        
7 Boats and planes ....        
8 Intellectual property ...        
9 Securities—Publicly traded . X 88 962,451 MARKET VALUE
10 Securities—Closely held stock .        
11 Securities—Partnership, LLC,
or trust interests .... 		       
12 Securities—Miscellaneous ..        
13 Qualified conservation
contribution—Historic
structures ..... 		       
14 Qualified conservation
contribution—Other ... 		       
15 Real estate—Residential .        
16 Real estate—Commercial ..        
17 Real estate—Other ...        
18 Collectibles .....        
19 Food inventory ... X 34    
20 Drugs and medical supplies .        
21 Taxidermy ......        
22 Historical artifacts ....        
23 Scientific specimens ..        
24 Archeological artifacts ...        
25 Other Right pointing arrow large image ( PRINTED ITEMS ) X 3    
26 Other Right pointing arrow large image ( FURNITURE&EQUIP ) X 5    
27 Other Right pointing arrow large image ( VARIOUS OTHERS ) X 39    
28 Other Right pointing arrow large image ( )
29
Number of Forms 8283 received by the organization during the tax year for contributions
for which the organization completed Form 8283, Part IV, Donee Acknowledgement ...
29
 
Yes
No
30a
During the year, did the organization receive by contribution any property reported in Part I, lines 1-28 that it
must hold for at least three years from the date of the initial contribution, and which is not required to be used
for exempt purposes for the entire holding period? ..................
30a
 
No
b
If "Yes," describe the arrangement in Part II.
31
Does the organization have a gift acceptance policy that requires the review of any non-standard contributions?
31
Yes
 
32a
Does the organization hire or use third parties or related organizations to solicit, process, or sell non-cash
contributions? ............................
32a
Yes
 
b
If "Yes," describe in Part II.
33
If the organization did not report revenues in column (c) for a type of property for which column (a) is checked,
describe in Part II.
For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 51227J
Schedule M (Form 990) 2010
Schedule M (Form 990) 2010
Page 2
Part II
Supplemental Information. Complete this part to provide the information required by Part I, lines 30b,
32b, and 33. Also complete this part for any additional information.
Identifier Return Reference Explanation
THIRD PARTY USED TO PROCESS NONCASH CONTRIBUTIONS SCHEDULE M, PAGE 1, PART I, LINE 32B LLS USES ITS INVESTMENT CUSTODIAN TO LIQUIDATE ANY DONATED SECURITIES.
EXPLANATION FOR NOT REPORTING REVENUE SCHEDULE M, PAGE 1, PART I, LINE 33 LLS ONLY RECORDS DONATED SECURITIES AS REVENUE. ALL OTHER ITEMS FOR WHICH COLUMN A IS CHECKED ARE NOT RECORDED AS REVENUE OR EXPENSE BECAUSE THEY WOULD NOT HAVE BEEN PURCHASED HAD THEY NOT BEEN DONATED, AND ARE IMMATERIAL IN AMOUNT RELATIVE TO THE STATEMENTS OF LLS.
SUPPLEMENTAL INFORMATION SCHEDULE M, PAGE 2, PART II PART I, COLUMN (B) LLS IS REPORTING THE NUMBER OF CONTRIBUTIONS FOR EACH OF THE ITEMS IN PART I, NOT THE NUMBER OF INDIVIDUAL ITEMS.
Schedule M (Form 990) 2010
Additional Data


Software ID:  
Software Version:  
SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
OMB No. 1545-0047
2010
Open to Public
Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Identifier Return Reference Explanation
FIRST ACHIEVEMENT DESCRIPTION FORM 990, PAGE 2, PART III, LINE 4A TO DATE, LLS HAS INVESTED MORE THAN 814 MILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2011, LLS SUPPORTED RESEARCH IN THE U.S., CANADA, AND 10 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF MORE THAN 66 MILLION. OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: -BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN BLOOD CANCER RESEARCH FIELDS. -TURNING DISCOVERIES INTO CLINICAL PROGRESS: BASIC SCIENCE DISCOVERIES MUST BE TRANSLATED INTO NEW, SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. -SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. -FILLING A VOID: PROMISING RESEARCH PROJECTS THAT ARE HIGH-RISK AND/OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY THE GOVERNMENT OR BY FOR-PROFIT COMPANIES, BUT MAY PROVIDE IMPORTANT ADVANCES. -INCREASING ACCESS TO CLINICAL TRIALS: PARTNERING WITH LEADING CLINICAL TRIAL CENTERS CAN ACCELERATE THE CLINICAL TESTING OF NEW BLOOD CANCER THERAPIES THAT ARE OFTEN A PATIENT'S BEST CHANCE FOR CURE. LLS RESEARCH PROGRAMS ARE BASED ON THE BELIEF THAT SCIENTIFICALLY SOUND APPROACHES TOWARD CURES FOR, OR CONTROL OF, BLOOD CANCERS SHOULD BE SUPPORTED WORLDWIDE.TWO MAJOR INTEGRATED RESEARCH FUNDING PROGRAMS THE RESEARCH GRANT PROGRAM AND THE THERAPY ACCELERATION PROGRAM HAVE ADVISORY INPUT FROM WORLD RENOWNED BIOMEDICAL RESEARCH EXPERTS. TOGETHER THESE PROGRAMS: -SUPPORT THE ENTIRE RESEARCH CONTINUUM NEEDED TO IMPROVE OUTCOMES FOR BLOOD CANCER PATIENTS FROM BASIC LABORATORY SCIENCE TO CLINICAL TRIALS OF NEW AGENTS AND FROM INVESTIGATOR INITIATED RESEARCH TO MULTIDISCIPLINARY ACADEMIC COLLABORATIONS AND PRIVATE SECTOR DRUG DEVELOPMENT ALLIANCES. -ARE AIMED AT THE EFFECTIVE DISCOVERY AND DEVELOPMENT OF NEW AND BETTER THERAPIES FOR PEOPLE WITH BLOOD CANCER, AND, THROUGH A RESEARCH INITIATIVE LAUNCHED IN 2009, SUPPORT THE DEVELOPMENT OF MEASURES TO PREVENT OR SIGNIFICANTLY REDUCE POTENTIAL LONG-TERM AND LATE TOXICITIES OF TODAY'S CURATIVE THERAPIES. RESEARCH GRANT PROGRAM THE RESEARCH GRANT PROGRAM PROVIDES GRANT FUNDING TO SUPPORT SCIENTIFIC STUDIES AT ACADEMIC CENTERS IN THE UNITED STATES AND THROUGHOUT THE WORLD, THROUGH THREE GRANT MECHANISMS: 1. THE CAREER DEVELOPMENT PROGRAM (CDP) PROVIDES STIPENDS TO INVESTIGATORS OF EXCEPTIONAL PROMISE IN THE EARLY STAGES OF THEIR CAREERS, HELPING THEM TO DEVOTE THEIR CAREERS TO LEUKEMIA, LYMPHOMA AND/OR MYELOMA RESEARCH. THIS PROGRAM IS STRATIFIED INTO TWO SEPARATELY REVIEWED PROGRAMS IN BASIC OR CLINICAL RESEARCH: -BASIC RESEARCH "SCHOLARS ARE AWARDED UP TO 110,000 A YEAR FOR A TOTAL OF UP TO 550,000 OVER FIVE YEARS. "SPECIAL FELLOWS ARE AWARDED UP TO 65,000 A YEAR FOR A TOTAL OF UP TO 195,000 OVER THREE YEARS. "FELLOWS ARE AWARDED UP TO 55,000 A YEAR FOR A TOTAL OF UP TO 165,000 OVER THREE YEARS. -CLINICAL RESEARCH "SCHOLARS IN CLINICAL RESEARCH ARE AWARDED UP TO 110,000 A YEAR FOR A TOTAL OF UP TO 550,000 OVER FIVE YEARS. "SPECIAL FELLOWS IN CLINICAL RESEARCH ARE AWARDED UP TO 65,000 A YEAR FOR A TOTAL OF UP TO 195,000 OVER THREE YEARS. 2. THE TRANSLATIONAL RESEARCH PROGRAM (TRP) SUPPORTS OUTSTANDING INVESTIGATIONS DEEMED BY OUR EXPERT ADVISORS MOST LIKELY TO TRANSLATE BASIC BIOMEDICAL DISCOVERIES INTO NEW, SAFE AND EFFECTIVE TREATMENTS, ULTIMATELY PROLONGING AND ENHANCING PATIENTS' LIVES. TRANSLATIONAL RESEARCH AWARDS ARE MADE FOR AN INITIAL THREE-YEAR PERIOD. AWARDS UP TO 200,000 PER YEAR FOR THREE YEARS, FOR A TOTAL OF UP TO 600,000, ARE GRANTED EACH YEAR. FUNDING FOR TWO ADDITIONAL YEARS MAY BE PROVIDED FOR HIGHLY PROMISING PROJECTS THAT ARE ENTERING PHASE 1 CLINICAL TRIALS. THUS, RESEARCH REACHING A CLINICAL TRIAL CAN RECEIVE UP TO 1 MILLION OVER FIVE YEARS TO FACILITATE NEW DRUG DISCOVERY OR ADVANCES IN DIAGNOSIS OR PREVENTION. IN 2011, LLS ACTIVELY REQUESTED PROPOSALS TO HELP STIMULATE MORE ACADEMIC RESEARCH IN THREE UNDERDEVELOPED YET IMPORTANT AREAS OF RESEARCH. THE RESEARCH TOPICS EMPHASIZED WERE: 1) THE MALIGNANT STEM CELL IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES; 2) NON-CUTANEOUS T-CELL LEUKEMIAS AND LYMPHOMAS AND 3) HIGH RISK MYELOMA CASES. IN ADDITION, A REQUEST FOR RESEARCH FOCUSED ON LONG-TERM AND LATE EFFECTS OF BLOOD CANCER THERAPIES WAS EXTENDED INTO A SECOND YEAR. PROGRESS IN THESE RESEARCH AREAS IS DEEMED LIKELY TO IMPROVE OUTCOMES FOR PATIENTS WITH PARTICULARLY URGENT NEEDS. 3. THE MARSHALL A. LICHTMAN SPECIALIZED CENTER OF RESEARCH PROGRAM (SCOR) ENCOURAGES MULTIDISCIPLINARY RESEARCH BY LEADING-EDGE ACADEMIC INVESTIGATORS IN TEAMS OF AT LEAST THREE RESEARCH GROUPS THAT INTERACT TO FOSTER ADVANCES IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF BLOOD CANCERS. EACH SCOR GROUP IS FUNDED UP TO 1.25 MILLION PER YEAR OVER A FIVE-YEAR PERIOD, WITH A TOTAL AMOUNT OF UP TO 6.25 MILLION. AWARDS GO TO THOSE GROUPS THAT BEST DEMONSTRATE SYNERGISTIC EXPERTISE IN COMPLEMENTARY AREAS . THE PARTICIPATING SCIENTISTS MAY BE AT DIFFERENT INSTITUTIONS OR FROM ANY COUNTRY. THE GRANT REVIEW PROCESS FOR THE RESEARCH GRANT PROGRAM. SCIENTISTS AND PHYSICIAN SCIENTISTS WHO ARE EXPERTS IN THE FIELD OF BLOOD CANCER RESEARCH VOLUNTEER THEIR SERVICE TO CONSTITUTE PEER-REVIEW SUBCOMMITTEES FOR BASIC RESEARCH CDP, CLINICAL RESEARCH CDP, TRP AND SCOR. THESE COMMITTEES EVALUATE ALL GRANT APPLICATIONS IN THOSE PROGRAMS AND SELECT THOSE APPLICANTS WITH THE MOST INNOVATIVE AND IMPORTANT PROJECTS TO ADVANCE THE MISSION OF LLS. GUIDELINES, INSTRUCTIONS AND APPLICATIONS FOR THE THREE LLS RESEARCH PROGRAMS MAY BE OBTAINED BY VISITING WWW.LLS.ORG OR BY EMAILING RESEARCHPROGRAMS@LLS.ORG. THERAPY ACCELERATION PROGRAM THE THERAPY ACCELERATION PROGRAM (TAP) IS A STRATEGIC LLS INITIATIVE LAUNCHED IN 2007 WITH 4 MILLION IN SEED FUNDING. THE PROGRAM ACCELERATES NEW AND POTENTIALLY BETTER TREATMENTS AND CLINICAL TESTS INTO PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS. WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS AND COMPANIES, TAP IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE MADE AVAILABLE TO PATIENTS AS SOON AS POSSIBLE. TAP ENCOMPASSES THREE INNOVATIVE EFFORTS: 1. THE ACADEMIC CONCIERGE DIVISION IDENTIFIES CURRENT LLS FUNDED RESEARCH WITH THE GREATEST CLINICAL PROMISE AND PROVIDES THE FUNDING AND SUPPORT NEEDED TO ADVANCE SELECTED PROJECTS TO THE PRODUCT STAGE. 2.THE CLINICAL TRIALS DIVISION PARTNERS LLS WITH ONE OF THE COUNTRY'S LEADING CLINICAL TRIAL CENTERS TO ACCELERATE THE TESTING OF NEW BLOOD CANCER THERAPIES IN CLINICAL TRIALS. 3. THE BIOTECHNOLOGY ACCELERATOR DIVISION ALLIES LLS WITH COMPANIES TO COMBINE SCIENTIFIC AND FINANCIAL RESOURCES AND ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES THAT OTHERWISE WOULD NOT BE PRIORITIZED BY THE COMPANY. THE TAP PROJECT REVIEW PROCESS INVOLVES DUE DILIGENCE BY AN LLS STAFF TEAM OF DRUG DEVELOPMENT SPECIALISTS IN CONCERT WITH A VOLUNTEER PANEL OF LEADING BIOTECHNOLOGY AND PHARMACEUTICAL COMPANY EXECUTIVES AND INTELLECTUAL PROPERTY AND BUSINESS DEVELOPMENT EXPERTS. THE LEARNING COLLABORATIVE IN 2011, LLS BEGAN A UNIQUE COLLABORATION WITH THE UNIVERSITY OF KANSAS CANCER CENTER AND THE NATIONAL INSTITUTES OF HEALTH TO ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES FOR RARE BLOOD CANCERS. THIS COLLABORATION, KNOWN AS THE LEARNING COLLABORATIVE, BRINGS TOGETHER PROVEN EXPERTISE IN BLOOD CANCER RESEARCH AS WELL AS DRUG DISCOVERY AND DEVELOPMENT TO RAPIDLY ADVANCE PROMISING NEW THERAPIES FROM THE BENCH TO THE BEDSIDE. IF SUCCESSFUL, THE LEARNING COLLABORATIVE'S NOVEL MODEL WILL DEMONSTRATE THAT GOVERNMENT, ACADEMIA, DISEASE PHILANTHROPY AND INDUSTRY CAN SUCCESSFULLY PARTNER TO SAFELY AND EFFICIENTLY ADVANCE NEW OR REPURPOSED DRUG THERAPIES TO PATIENTS.
SECOND ACHIEVEMENT DESCRIPTION FORM 990, PAGE 2, PART III, LINE 4B CHAPTER-BASED PROGRAMS: EACH LLS CHAPTER IS STAFFED WITH A PATIENT SERVICES MANAGER WHO OVERSEES THE CHAPTER'S SERVICES TO PATIENTS AND THEIR FAMILIES. PATIENT SERVICES MANAGERS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. COMMUNITY BASED EDUCATION, INCLUDING THE FOLLOWING FOUR PROGRAMS, ARE OFFERED THROUGH ALL THE CHAPTERS - 38,959 PATIENT AND CAREGIVER PARTICIPANTS IN 2011 - 12,236 HEALTHCARE PROFESSIONAL PARTICIPANTS IN 2011 IMPROVING TREATMENTS FOR BLOOD CANCERS: WHAT YOU NEED TO KNOW TO MAKE INFORMED DECISIONS THIS PROGRAM DETAILS NEW TREATMENT DEVELOPMENT, TREATMENT DECISIONS (STANDARD OF CARE VERSUS CLINICAL TRIALS) AND HOW PATIENTS CAN COMMUNICATE MORE EFFECTIVELY WITH THEIR MEDICAL TEAMS. MYELOMA UPDATE: DIAGNOSIS, TREATMENT AND SIDE EFFECTS MANAGEMENT THIS PROGRAM PROVIDES PATIENTS, FAMILY MEMBERS AND CAREGIVERS WITH THE LATEST INFORMATION ON MYELOMA AND MYELOMA THERAPY, INCLUDING A QUESTION AND ANSWER SESSION WITH A MEDICAL EXPERT IN THEIR COMMUNITY. GETTING THE BEST CANCER CARE AT AGE 55 AND OLDER THIS EDUCATION PROGRAM PRESENTS AN OVERVIEW OF THE MANY FACTORS, NOT AGE ALONE, THAT HEALTHCARE PROFESSIONALS SHOULD ASSESS TO DETERMINE AN APPROPRIATE CANCER TREATMENT PLAN FOR AN OLDER ADULT. WELCOME BACK: WORKING TOGETHER TO SUPPORT THE CANCER SURVIVOR AT SCHOOL THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN IMPROVE THE TRANSITION OF CANCER SURVIVORS FROM CLINIC TO CLASSROOM. SUPPORT SERVICES: FAMILY SUPPORT GROUPS LLS HAS DEVELOPED 452 FAMILY SUPPORT GROUPS AT CHAPTERS THROUGHOUT THE US AND CANADA. LLS ALSO HAS 825 VOLUNTEER SUPPORT GROUP FACILITATORS WITH BACKGROUNDS IN ONCOLOGY NURSING OR SOCIAL WORK. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, AND PROVIDE INFORMATION AND SUPPORT AND ENCOURAGE GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTH CARE PROFESSIONALS. - 13,108 PARTICIPANTS IN FAMILY SUPPORT GROUPS IN 2011 PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. - 5,094 FIRST CONNECTIONS IN 2011 PATIENT FINANCIAL AID PROGRAM FOR MORE THAN 45 YEARS, LLS HAS HELPED PATIENTS DEMONSTRATING SIGNIFICANT NEED TO OBTAIN FINANCIAL ASSISTANCE TO COVER A PORTION OF THEIR TREATMENT COSTS. THE LLS PATIENT FINANCIAL AID PROGRAM PROVIDES A LIMITED AMOUNT OF FINANCIAL ASSISTANCE TO HELP PATIENTS WITH SIGNIFICANT FINANCIAL NEED AND WHO ARE UNDER A DOCTOR'S CARE FOR A CONFIRMED BLOOD CANCER DIAGNOSIS. PATIENT FINANCIAL AID FUNDS ARE SUBJECT TO AVAILABILITY. - 37,210 PATIENTS RECEIVED FINANCIAL AID IN 2011 CO-PAY ASSISTANCE PROGRAM THIS ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. - 13,130 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2011 THE TRISH GREENE BACK TO SCHOOL PROGRAM FOR CHILDREN WITH CANCER THIS PROGRAM IS DESIGNED TO INCREASE COMMUNICATION AMONG HEALTH CARE PROFESSIONALS, PARENTS, PATIENTS AND SCHOOL PERSONNEL TO ASSURE YOUNGSTERS A SMOOTH TRANSITION FROM ACTIVE TREATMENT BACK TO SCHOOL. PRINTED LITERATURE, VIDEOS AND OTHER MATERIALS TO AID THE PROCESS ARE AVAILABLE THROUGH ALL LOCAL CHAPTERS, INCLUDING: "WELCOME BACK: WORKING TOGETHER TO SUPPORT THE CANCER SURVIVOR AT SCHOOL". THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN IMPROVE THE TRANSITION OF CANCER SURVIVORS FROM CLINIC TO CLASSROOM. - 3,219 SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS PARTICIPATED IN THE 74 WELCOME BACK PROGRAMS ACROSS THE US AND CANADA "LEARNING AND LIVING WITH CANCER: ADVOCATING FOR YOUR CHILD'S EDUCATIONAL NEEDS" THIS BOOKLET OFFERS PARENTS INFORMATION ON THE LEARNING CHALLENGES CHILDREN MAY FACE DURING AND AFTER CANCER TREATMENT, LAWS THAT PROTECT THE EDUCATIONAL NEEDS OF CHILDREN WITH CANCER AND SPECIFIC WAYS THAT SCHOOLS CAN HELP MEET A CHILD'S EDUCATIONAL NEEDS
THIRD ACHIEVEMENT DESCRIPTION FORM 990, PAGE 2, PART III, LINE 4C PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS MAY SPEAK TO AN INFORMATION SPECIALIST AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 6 P.M., ET OR EMAIL INFOCENTER@LLS.ORG. - 69,777 INQUIRIES IN 2011 - TRANSLATION SERVICES AVAILABLE IN MORE THAN 165 LANGUAGES ONLINE ENGAGEMENT THE LLS WEBSITE SERVES A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. USERS CAN PERSONALIZE THEIR LLS WEB PAGES TO KEEP CURRENT WITH DISEASE SPECIFIC UPDATES AND LOCAL CHAPTER EDUCATION, SUPPORT AND EVENT ACTIVITIES. THE SITE FEATURES A COMPREHENSIVE OVERVIEW OF LLS PROGRAMS AND SERVICES, FAMILY SUPPORT GROUP LOCATIONS, INFORMATION ABOUT OUR PEER-TO-PEER PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM, AND OTHER PROGRAMS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS IN CONVENIENT AND PERSONAL WAYS THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. - 5.8 MILLION UNIQUE VISITS TO WWW.LLS.ORG IN 2011, WITH MORE THAN 7.5 MILLION PAGE VIEWS - 409,799 UNIQUE VISITS TO OUR BLOOD CANCER DISCUSSION BOARDS - 157,877 TELECONFERENCE DOWNLOADS - 208,822 SUBSCRIBERS TO OUR DISEASE SPECIFIC ENEWSLETTERS, WHICH ARE ISSUED ON A MONTHLY BASIS - 116,797 FOLLOWERS OF OUR PATIENT AND CAREGIVER COMMUNITY ONLINE TELEPHONE & WEB EDUCATION PROGRAMS LLS SPONSORS TELEPHONE AND WEB EDUCATION PROGRAMS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTHCARE PROFESSIONALS ABOUT LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. UPCOMING PROGRAMS ARE POSTED AT WWW.LLS.ORG/PROGRAMS AND ARCHIVES OF PAST PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PASTPROGRAMS. - 251,077 TELEPHONE AND WEB-BASED PROGRAM PARTICIPANTS IN 2011 EDUCATION MATERIALS AN EXTENSIVE CATALOG OF EDUCATION MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTHCARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LOCAL LLS CHAPTERS. - 1,061,018 PRINTED BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS DISTRIBUTED IN 2011 MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/RESOURCECENTER. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH, SPANISH AND FRENCH.
ALL OTHER ACHIEVEMENTS DESCRIPTION FORM 990, PAGE 2, PART III, LINE 4D D) PROFESSIONAL EDUCATION: LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT.
FINANCIAL ACCOUNTS IN FOREIGN COUNTRIES FORM 990, PART V, LINE 4B CANADA
CLASSES OF MEMBERS OR STOCKHOLDERS FORM 990, PAGE 6, PART VI, LINE 6 THE MEMBERS OF LLS CONSIST OF ONE ELECTED REPRESENTATIVE FROM EACH CHAPTER.
ELECTION OF MEMBERS AND THEIR RIGHTS FORM 990, PAGE 6, PART VI, LINE 7A THE BOARD OF REPRESENTATIVES (REPRESENTING THE CHAPTERS) ELECTS THE MEMBERS OF LLS'S GOVERNING BODY, ITS NATIONAL BOARD OF DIRECTORS.
DECISIONS SUBJECT TO APPROVAL OF MEMBERS FORM 990, PAGE 6, PART VI, LINE 7B SIGNIFICANT DECISIONS AFFECTING THE CHAPTERS REQUIRE AN APPROVING VOTE BY THE CHAPTER DELEGATES. DECISIONS NOT SIGNIFICANTLY AFFECTING THE CHAPTERS DO NOT REQUIRE APPROVAL FROM THE CHAPTER DELEGATES.
ORGANIZATION'S PROCESS USED TO REVIEW FORM 990 FORM 990, PAGE 6, PART VI, LINE 11B THE FORM 990 WAS PREPARED BY THE LLS FINANCE DEPARTMENT AND WAS REVIEWED BY THE CFO, VICE PRESIDENT OF FINANCE, AND KPMG FOR COMMENT AND SUGGESTED REVISIONS. THE FORM 990 WAS THEN PROVIDED TO THE AUDIT COMMITTEE, WHICH IS A COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWED THE 990 AND PROVIDED INPUT PRIOR TO FILING. THE FINAL DRAFT FORM 990 WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING BY POSTING THE FORM ON AN INTRANET WEBSITE.
ENFORCEMENT OF CONFLICTS POLICY FORM 990, PAGE 6, PART VI, LINE 12C ALL EMPLOYEES, BOARD OF DIRECTORS MEMBERS, BOARD OF REPRESENTATIVES MEMBERS, CHAPTER BOARD MEMBERS, FAMILY SUPPORT GROUP FACILITATORS, AND TNT COACHES ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY ON AN ANNUAL BASIS AND SUBMIT A SIGNED FORM ACKNOWLEDGING THAT THEY HAVE REVIEWED THE POLICY AND DISCLOSED ANY CONFLICTS OF INTEREST. ALL FORMS ARE COLLECTED AND THE AUDIT COMMITTEE REVIEWS ANY FORMS DISCLOSING A POSSIBLE CONFLICT OF INTEREST AND DETERMINES WHETHER OR NOT A CONFLICT EXISTS.
COMPENSATION PROCESS FOR TOP OFFICIAL FORM 990, PAGE 6, PART VI, LINE 15A THE EXECUTIVE COMMITTEE, COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, REVIEWS AND MONITORS THE CHIEF EXECUTIVE OFFICER'S PERFORMANCE AND COMPENSATION. THE COMMITTEE OBTAINED A SURVEY OF OTHER NOT-FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND SET THE CHIEF EXECUTIVE'S SALARY COMMENSURATELY. THE REVIEW WAS DOCUMENTED IN THE EXECUTIVE COMMITTEE'S MINUTES.
COMPENSATION PROCESS FOR OFFICERS FORM 990, PAGE 6, PART VI, LINE 15B THE EXECUTIVE COMMITTEE, COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, REVIEWED A SURVEY OF OTHER NOT-FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND COMPARED THIS TO THE OTHER OFFICER'S SALARY AND DETERMINED THAT IT WAS APPROPRIATE. THE REVIEW WAS DOCUMENTED IN THE EXECUTIVE COMMITTEE'S MINUTES.
STATES WHERE COPY OF RETURN IS FILED FORM 990, PAGE 6, PART VI, LINE 17 ALASKA, ARKANSAS, ARIZONA, CALIFORNIA, CONNECTICUT, DELAWARE, FLORIDA, GEORGIA, ILLINOIS, INDIANA, KANSAS, KENTUCKY, LOUISIANA, MASSACHUSETTS, MARYLAND, MAINE, MICHIGAN, MINNESOTA, MISSOURI, MISSISSIPPI, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEVADA, NEW YORK, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, PUERTO RICO, RHODE ISLAND, SOUTH CAROLINA, TENNESSEE, UTAH, VIRGINIA, WASHINGTON, WISCONSIN, WEST VIRGINIA
GOVERNING DOCUMENTS DISCLOSURE EXPLANATION FORM 990, PAGE 6, PART VI, LINE 19 THE LEUKEMIA & LYMPHOMA SOCIETY, INC. MAKES ITS ANNUAL FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE AT WWW.LLS.ORG. ITS GOVERNING DOCUMENTS ARE MADE AVAILABLE, WHEN CHANGES ARE MADE, AS PART OF THE 990 AVAILABLE FOR PUBLIC INSPECTION. ANY IDENTIFIED CONFLICTS OF INTEREST ARE DISCLOSED IN THE 990.
ADDITIONAL INFORMATION FORM 990, PART VII SECTION B, LINE 1
OTHER CHANGES IN NET ASSETS EXPLANATION FORM 990, PART XI, LINE 5 RECONCILIATION OF CHANGE IN NET ASSETS ON A CONSOLIDATED BASIS TO SEPARATE COMPANY BASIS: CHANGE IN NET ASSETS PER AUDITED FINANCIAL STATEMENTS 10,432,000 PLUS: CHANGE IN NET ASSETS LLS CANADA 183,453 PLUS: LLSRF AND LLSRP ACTIVITY 39,395 PLUS: FOREIGN CURRENCY TRANSLATION ADJUSTMENT (320,000) PLUS: AUDITED FINANCIAL STATEMENT ROUNDING 1,976 EQUALS: CHANGE IN NET ASSETS PER 990 10,336,824 SCHEDULE D PART XI LINE 9 7,440,623 CHANGE IN NET ASSETS ABOVE (95,176) 990 PART XI LINE 5 7,345,447 THE AUDITED FINANCIAL STATEMENTS FOR THE LEUKEMIA & LYMPHOMA SOCIETY, INC. INCLUDE THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA, THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH PROGRAMS, INC., AND THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH FOUNDATION IN ADDITION TO LLS.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2010

Additional Data


Software ID:  
Software Version:  
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
MediumBulletComplete if the organization answered "Yes" to Form 990, Part IV, line 33, 34, 35, 36, or 37.
MediumBulletAttach to Form 990. MediumBullet See separate instructions.

OMB No. 1545-0047
2010
Open to Public Inspection
Name of the organization
THE LEUKEMIA & LYMPHOMA
SOCIETY INC
Employer identification number

13-5644916
Part I
Identification of Disregarded Entities (Complete if the organization answered "Yes" on Form 990, Part IV, line 33.)
(a)
Name, address, and EIN of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income
(e)
End-of-year assets


 		(f)
Direct controlling
entity

















Part II
Identification of Related Tax-Exempt Organizations (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.)
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section
(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled organization
Yes No
(1) THE LLS OF CANADA

804-2 LANSING SQUARE
TORONTO   M2J4P8
CA
PART VII CA     N/A
 
No
(2) THE LLS RESEARCH PROGRAMS INC

1311 MAMARONECK AVENUE

WHITE PLAINS,NY10605
13-3470494 		PART VII DE 501C3 11B LLS INC
 
Yes
 
(3) THE LLS RESEARCH FOUNDATION

1311 MAMARONECK AVENUE

WHITE PLAINS,NY10605
13-3709252 		PART VII DE 501C3 11B LLS INC
 
Yes
 








For Privacy Act and Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2010
Schedule R (Form 990) 2010
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.)
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V—UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No












Part IV
Identification of Related Organizations Taxable as a Corporation or Trust (Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.)
(a)
Name, address, and EIN of related organization



 		(b)
Primary activity



 		(c)
Legal domicile
(state or
foreign
country)
 		(d)
Direct controlling
entity


 		(e)
Type of entity
(C corp, S corp,
or trust)

 		(f)
Share of total income



 		(g)
Share of
end-of-year
assets

 		(h)
Percentage
ownership
(1) ROY & ANN BERGER
201 LINCOLN AVENUE
NORWELL,MA02061
99-9999999 		CRUT NH N/A
 TRUST 53,892   100.000 %












Schedule R (Form 990) 2010
Schedule R (Form 990) 2010
Page 3
Part V
Transactions With Related Organizations (Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35, 35A, or 36.)
Note. Complete line 1 if any entity is listed in Parts II, III or IV.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest (ii) annuities (iii) royalties (iv) rent from a controlled entity . . . . . . . . . . . . . . . . . . . . . . .
1a
 
No
b Gift, grant, or capital contribution to other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1b
 
No
c Gift, grant, or capital contribution from other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1c
Yes
 
d Loans or loan guarantees to or for other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1d
Yes
 
e Loans or loan guarantees by other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1e
 
No
f Sale of assets to other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1f
 
No
g Purchase of assets from other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1g
 
No
h Exchange of assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1h
 
No
i Lease of facilities, equipment, or other assets to other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1i
 
No
j Lease of facilities, equipment, or other assets from other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . .
1j
 
No
k Performance of services or membership or fundraising solicitations for other organization(s) . . . . . . . . . . . . . . . . . . . . . .
1k
 
No
l Performance of services or membership or fundraising solicitations by other organization(s) . . . . . . . . . . . . . . . . . . . . . .
1l
 
No
m Sharing of facilities, equipment, mailing lists, or other assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1m
Yes
 
n Sharing of paid employees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1n
Yes
 
o Reimbursement paid to other organization for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1o
 
No
p Reimbursement paid by other organization for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1p
 
No
q Other transfer of cash or property to other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1q
 
No
r Other transfer of cash or property from other organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1r
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of other organization 		(b)
Transaction
type(a-r) 		(c)
Amount involved 		(d)
Method of determining amount involved
(1) THE LEUKEMIA & LYMPHOMA SOCIETY

 D 135,950 COST
(2) OF CANADA

      
(3)
(4)
(5)
(6)
Schedule R (Form 990) 2010
Schedule R (Form 990) 2010
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership (Complete if the organization answered "Yes" on Form 990, Part IV, line 37.)
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Are all
partners
section
501(c)(3)
organizations? 		(e)
Share of
end-of-year
assets 		(f)
Disproprtionate allocations? 		(g)
Code V—UBI
amount in box
20 of Schedule K-1
(Form 1065) 		(h)
General or
managing
partner?
Yes No Yes No Yes No






























Schedule R (Form 990) 2010
Schedule R (Form 990) 2010
Page 5
Part VII
Supplemental Information
Complete this part to provide additional information for responses to questions on Schedule R (see instructions).
Identifier Return Reference Explanation
GROUP EXEMPTION RELATIONSHIPS SCHEDULE R SCHEDULE R PART II COLUMN B THE LEUKEMIA LYMPHOMA SOCIETY OF CANADA CARRIES OUT THE SAME PRIMARY ACTIVITIES AS THE LEUKEMIA LYMPHOMA SOCIETYINC IN CANADA THE LEUKEMIA LYMPHOMA SOCIETY RESEARCH PROGRAMSINC AND THE LEUKEMIA LYMPHOMA SOCIETY RESEARCH FOUNDATION SUPPORT THE ACTIVITIES OF THE LEUKEMIA LYMPHOMA SOCIETY INC
Additional Data


Software ID:  
Software Version: